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ABSTRACT 
 
SUSAN CASPER ANENBERG: Using Atmospheric Models to Estimate Global Air 
Pollution Mortality 
(Under the direction of J. Jason West) 
 
 Ground-level ozone and fine particulate matter (PM2.5) are associated with 
premature mortality and can influence air quality on global scales.  This work examines 
the global health impacts of ozone and PM2.5 using concentrations simulated by global 
chemical transport models (CTMs), which allow full spatial coverage and analysis of 
hypothetical changes in emissions.  Here, previous methods using global models are 
improved by using cause-specific and country-specific baseline mortality rates, and by 
using area-weighted average rates where gridcells overlap multiple countries.  
 Using these methods, we estimate 0.7 ± 0.3 and 3.7 ± 1.0 million global 
premature deaths annually due to anthropogenic ozone and PM2.5, found as the difference 
between simulations with and without anthropogenic emissions.   PM2.5 mortality 
estimates are ~50% higher than previous measurement-based estimates based on common 
assumptions, mainly because rural populations are included, suggesting higher estimates, 
although the coarsely resolved global atmospheric model may underestimate urban PM2.5 
exposures.   Estimating the mortality impacts of intercontinental transport of ozone shows 
that for North America, East Asia, South Asia, and Europe, foreign ozone precursor 
emission reductions contribute ~30%, 30%, 20%, and >50% of the deaths avoided by 
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reducing emissions in all regions together.  For North America and Europe, reducing 
precursor emissions avoids more deaths outside the source region than within, due mainly 
to larger foreign populations.  Finally, using the MOZART-4 global CTM, we estimate 
that halving global anthropogenic black carbon (BC) emissions reduces population-
weighted average PM2.5 by 542 ng/m
3
 (1.8%) and avoids 157,000 (95% confidence 
interval, 120,000-194,000) annual premature deaths globally, with the vast majority 
occurring within the source region. Over 80% of these deaths occur in Asia, with 50% 
greater mortality impacts per unit BC emitted for South Asian versus East Asian 
emissions. Globally, the contribution of residential, industrial, and transportation BC 
emissions to BC-related mortality is 1.3, 1.2, and 0.6 times each sector’s contribution to 
anthropogenic BC emissions, owing to the degree of co-location with population. 
 Future research should improve upon the many sources of uncertainty, 
incorporate shifting demographics, and examine the health impacts of realistic emission 
control technologies, which would affect emissions of multiple species simultaneously.  
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Chapter 1. Introduction 
 
 Tropospheric (ground-level) ozone (O3) and fine particulate matter (PM2.5) are 
associated with deleterious health impacts, including premature mortality (e.g. Jerrett et 
al. 2009; Krewski et al. 2009).  Concentrations of these pollutants have increased 
substantially since preindustrial times as a result of human activity (Volz and Kley 1988; 
Staehelin et al. 2001; Ginoux et al. 2006; Horowitz 2006; Schultz et al. 2006).  In some 
countries, regulation has successfully improved air quality over recent decades (e.g. US 
EPA 2008b).  However, air pollution continues to be a serious detriment to public health, 
particularly in rapidly developing countries where emissions continue to rise (Cohen et 
al. 2004; Lamarque et al. 2010; TF HTAP 2010).   
 Recent studies show that air pollution emissions from one region can influence air 
quality in other regions, with far-reaching impacts on health and the environment (e.g. 
National Academy of Sciences 2009; TF HTAP 2010).  Air pollution is thus increasingly 
viewed as a global problem requiring international solutions (Holloway et al. 2003; 
Keating et al. 2004; Global Atmospheric Pollution Forum 2010; TF HTAP 2010).  
Furthermore, air pollution and climate are interrelated, and consideration of both health 
and climate impacts of air pollution can lead to identification of policies that benefit both 
simultaneously (e.g. Jacobson 2002; Bond and Sun 2005; Ramanathan and Carmichael 
2008; Kopp and Mauzerall 2010).   
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 Multi-national cooperation in air pollution mitigation will require tools to assess 
the health benefits of alternative mitigation strategies.  This dissertation is aimed at 
assessing the impacts of global air pollution and its mitigation on global public health, 
and in doing so, identifying limitations and uncertainties that should be addressed to 
improve the utility of global health impact assessment in informing policy decisions.   
 
1.1. Air pollution and its health impacts  
 Air pollution is a heterogeneous mixture of gaseous and particulate components.  
O3 and PM2.5 are two of the most ubiquitous air pollutants that have both been 
demonstrated to cause negative health impacts, including premature mortality.  O3 is not 
emitted directly, but is formed through photochemical reaction of precursor species, 
nitrogen oxides (NOx) and volatile organic compounds (VOCs). O3 precursors are 
produced both naturally by vegetation and soil, and anthropogenically through fuel 
combustion and industrial processes. Particulate matter (PM) is both emitted directly and 
formed indirectly through reaction in the atmosphere. Coarse PM (PM10), between 2.5 
and 10 µm in diameter, is largely transferred to the atmosphere by natural physical 
processes, such as wind-produced dust and sea salt. Conversely, fine PM (PM2.5), ≤2.5 
µm in diameter, is emitted by anthropogenic sources or produced by reaction of gaseous 
emissions, such as nitrogen and sulfur oxides, in the atmosphere. PM2.5 composition is 
nonuniform, depending on source and chemical processing in the atmosphere, such as 
absorption of gases onto the surface of particles, adhesion, coagulation, and hydroscopic 
growth. Thus, the general term PM2.5 does not capture significant differences in aerosol 
composition around the world. PM2.5 is associated with more deleterious health effects 
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than coarse PM, because these tiny particles can penetrate deep into the lungs and may 
consist of more toxic materials (Pope and Dockery 2006). 
 Ground-level concentrations of O3 and PM2.5 have increased substantially since 
preindustrial times (Volz and Kley 1988; Staehelin et al. 2001; Ginoux et al. 2006; 
Horowitz 2006; Schulz et al. 2006). While O3 mitigation has traditionally focused on 
urban areas in developed regions, observation and modeling studies show that O3 
produced in polluted regions can be transported long distances and that transport of 
precursors can enhance O3 production in remote regions, impacting air quality on a global 
scale (TF HTAP 2007; Fiore et al. 2009; National Academy of Sciences 2009; West et al. 
2009a; TF HTAP 2010). As a result, the global background concentration of O3 has 
roughly doubled that in preindustrial times (Volz and Kley 1988; Akimoto 2003; 
Vingarzan 2004; TF HTAP 2010). Though the lifetime of PM2.5 (days to weeks) is shorter 
than that of O3 (weeks to months), it is also long enough that it can distribute to form 
elevated regional background concentrations (Akimoto 2003; Liu et al. 2009b; TF HTAP 
2010).  
 
1.1.1. Air pollution epidemiology 
 Evidence for health effects of air pollution come from both controlled exposure 
studies and epidemiology studies.  Epidemiology studies find statistical relationships 
between observed ambient air pollutant concentrations and health effects over large 
populations.  Unlike cellular, animal, and even human controlled exposure studies, 
epidemiology studies assess real-world human responses to air pollution and therefore 
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generally provide a more realistic assessment of the health effects of actual air pollution 
exposures.   
 The first air pollution epidemiology studies examined very severe air pollution 
episodes, such as the London Smog episode in 1952, where an air inversion kept 
pollution from coal combustion close to the ground.  Researchers later compared daily 
mortality with pollution concentrations, finding about 12,000 deaths attributable to the 
incident (Figure 1.1) (Bell et al. 2001).  Modern air pollution epidemiology studies 
leverage extensive monitoring networks in the US and Europe and detailed health 
information to find statistical relationships across many cities and over long time periods.  
These studies measure relative risk (RR), the ratio of the probability of an event 
occurring in an exposed group versus in an unexposed group.  When RR=1, the risk 
factor has no effect.  When RR>1 the risk factor causes a risk increase in the exposed 
group compared with the unexposed group.  Conversely, if the RR<1, the risk factor 
actually has a protective effect.  For example, estimated RR of mortality associated with 
ambient PM2.5 concentration is greater than 1, particularly for lung cancer and 
cardiopulmonary mortality (Figure 1.2) (Pope et al. 2002; Pope and Dockery 2006).  
 As described in the next sections, the evidence for health effects of air pollution is 
now well established and widely accepted.  Short-term studies from around the world and 
several large-scale long-term studies in the US and Europe find that PM2.5 is associated 
with increased mortality.  A large body of literature also finds that short-term O3 
exposure is associated with increased daily mortality, and recent evidence from one long-
term study in the US also links O3 with respiratory mortality.  The major air pollution 
epidemiology studies generally find that the natural log of RR varies linearly with 
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concentration, with the slope of the association termed the ―concentration-response 
factor‖ (CRF).  Current epidemiological evidence finds that PM2.5 generally has a 
stronger relationship with mortality than does O3. 
 
1.1.2. Ambient PM2.5 concentrations and mortality  
 The health effects of chronic exposure to ambient PM2.5 concentrations are well 
established by long-term epidemiology studies that examine associations between 
elevated PM2.5 concentrations and deleterious health outcomes, such as premature 
mortality. The first major PM2.5 cohort study was the ―Harvard Six Cities study,‖ which 
examined PM2.5 concentrations and mortality in six US cities, finding a significant 
association between elevated PM2.5 concentrations and mortality (Dockery et al. 1993). 
The Harvard Six Cities study was later reanalyzed with additional years of follow-up, 
during which PM2.5 levels decreased in the six cities (Laden et al. 2006). This study 
found that when PM2.5 concentrations decreased, mortality also decreased, reaffirming the 
strong association between PM2.5 and mortality, and demonstrating that the association is 
reversible when PM2.5 is controlled.  In this latest reanalysis, relative risk of all-cause, 
cardiovascular, and lung cancer mortality was 1.16 (95% confidence interval [CI], 1.07-
1.26), 1.28 (1.13-1.44), and 1.27 (0.96-1.69) for a 10 µg/m
3
 increase in PM2.5 (Laden et 
al. 2006). 
 Positive associations have also been found by the American Cancer Society 
(ACS) study, which has a larger cohort from all major urban areas within the US.  The 
ACS study has been extended and reanalyzed several times with consistent findings of a 
strong association between PM2.5 concentrations and excess all-cause, cardiopulmonary, 
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and lung cancer mortality (e.g. Pope et al. 2002; Krewski et al. 2009). The most recent 
reanalysis found that for a 10 µg/m
3
 increase in PM2.5, relative risk of total, 
cardiopulmonary, and lung cancer mortality was 1.06 (95% CI, 1.04-1.08), 1.13 (1.10-
1.16), and 1.14 (1.06-1.23) (Krewski et al. 2009).  The ACS study includes 
approximately 500,000 adults age 30 and older from over 150 metropolitan areas, a larger 
cohort than any other PM2.5 cohort study.   
 Both the Harvard Six Cities and ACS studies are consistent in the strong positive 
association found between PM2.5 concentration and mortality, but relative risk estimates 
from the Harvard Six Cities study are substantially larger than estimates from the ACS 
study.  In 2008, US EPA sponsored an expert elicitation of this relationship which 
produced a mean that was between the relative risk estimates from these two studies 
(Roman et al. 2008).  No long-term PM2.5 cohort study to date has been conducted outside 
of the US and Europe, and extrapolation of these relationships found in the US to the rest 
of the world is uncertain, but is supported by meta-analyses finding that short-term 
mortality studies around the world find generally consistent results (Health Effects 
Institute 2010; Atkinson et al. 2011).  While both studies are used by US EPA to estimate 
the health benefits of regulations in the US, the ACS study is generally used more often 
in global health impact assessments, since it includes the largest population.  However, 
the ACS cohort overrepresented well-educated individuals in the US who were found to 
have a lower relative risk of PM2.5-related mortality (Pope and Dockery 2005).  Thus, 
health impact assessments based on the ACS cohort may be underestimates.    
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1.1.3. Ambient ozone concentrations and mortality 
  Many short-term epidemiology studies have implicated acute O3 exposure as a 
serious health detriment, finding that elevated O3 concentrations are associated with daily 
mortality (e.g. Bell et al. 2005; Ito et al. 2005; Levy et al. 2005). These studies typically 
examine O3 concentrations and mortality in one US city, which limits the ability to 
generalize findings to the entire population. A larger study that included 95 US urban 
communities confirmed the earlier associations, finding that a 10 ppb increase in daily 
average O3 concentrations was associated with a 0.52% (95% posterior interval [PI], 
0.27%-0.77%) increase in total mortality and a 0.64% (95% PI, 0.31%-0.98%) increase in 
cardiovascular and respiratory mortality (Bell et al. 2004).   Short-term O3 mortality 
studies around the world generally find consistent O3 mortality relationships (Anderson et 
al. 2004; Atkinson et al. 2011) 
 Only recently, a large-scale long-term cohort study based on the American Cancer 
Society cohort found an association between chronic O3 exposure and mortality (Jerrett et 
al. 2009).  This study found that only respiratory mortality was significantly associated 
with O3 exposure when PM2.5 concentrations were included in the model. For a 10 ppb 
increase in the seasonal (6 month) average of 1-hour daily maximum O3 concentrations, 
respiratory mortality increased by 4% (95% CI, 1.3%-6.7%). While this is the first large-
scale cohort study to demonstrate effects of long-term O3 exposure on mortality, evidence 
of O3 effects on developmental respiratory effects such as lung function and asthma 
induction and exacerbation suggest biological plausibility (National Academy of 
Sciences 2008).  In addition, previous smaller scale cohort studies have also found 
positive associations (National Academy of Sciences 2008).  Continuing research on 
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chronic O3 exposure and mortality is expected to further elucidate long-term risk of 
mortality from O3 exposure.  Prior to this work, studies assessing the global health 
impacts of O3 have used short-term mortality relationships.  This work is the first to begin 
using chronic O3 mortality estimates from Jerrett et al. (2009) for health impact 
assessment. 
 
1.2. Air pollution in a global context 
 Evidence for associations between these pollutants and human health endpoints 
found by short-term and long-term epidemiology studies have formed the basis for 
regulatory action in the US, Europe, and many other countries. In the US, both O3 and 
PM are regulated by National Ambient Air Quality Standards (NAAQS), which are set by 
US EPA to protect human health without regard to cost. NAAQS were first established in 
1970 and are continually strengthened over time to reflect new scientific understanding.  
In 2008, the daily 8-hr. maximum standard for O3 was lowered from 0.08 parts per 
million (ppm) to 0.075 ppm, and it is currently being reconsidered at a range that is more 
protective of public health (0.06-0.07 ppm). While the original NAAQS for PM was 
based on PM10, a separate standard for PM2.5 was set in 1997 after linkages were found 
between PM2.5 and health problems, such as increased hospital admissions, emergency 
room visits, and premature death for people with lung and heart disease. The annual 
average PM10 standard was eventually revoked in 2006 because evidence does not 
suggest a link between long-term exposure to PM10 and deleterious health effects, 
although the 24-hr. average standard of 150 µg/m
3 
was retained. The current standard for 
annual average PM2.5 is 15 µg/m
3
.   
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 NAAQS have been very effective at reducing PM2.5 and O3 concentrations in the 
US (Figure 1.3) (US EPA 2008b) with large benefits to public health that continue as 
downward emission trends persist (Hubbell et al. 2004; Fann and Risley 2011).  
However, evidence suggests that air pollution affects health at levels lower than current 
standards (e.g. Jerrett et al. 2009; Krewski et al. 2009; Kim et al. 2011).  Furthermore, 
emissions are rising in many places around the world, most notably in China and India, 
due to rapid economic development and limited regulation (Lamarque et al. 2010; TF 
HTAP 2010).  Since air pollution can travel long distances, impacting air quality and 
public health far from the emission source (Figure 1.4) (e.g. National Academy of 
Sciences 2009; TF HTAP 2010), strategies to control local pollution that have been 
widely successful in the past may not be as sufficient to protect public health in the future 
as emissions around the world continue to rise (Keating et al. 2004).  In sum, the 
contribution of local emission sources to concentrations is decreasing in many developed 
countries as a result of tight regulation while the contribution from foreign emissions is 
rapidly growing (Figure 1.5).  These factors combined suggest a need for international 
cooperation in controlling air pollution.  
 Air pollution and global climate change are also interrelated, suggesting that these 
problems should be considered together in designing mitigation strategies.  First, 
warming temperatures and more frequent air inversions are expected to exacerbate air 
pollution episodes (e.g. Bloomer et al. 2009; Jacob et al. 2009).  Additionally, some 
pollutants traditionally regulated for their impacts on health, such as O3 and components 
of PM2.5, also affect climate by directly absorbing or reflecting solar radiation, indirectly 
impacting cloud lifetime and reflectivity, and reducing snow and ice albedo (e.g. Horvath 
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1993, Hansen and Nazarenko 2004, Koch and Del Genio 2010).  Finally, the sources of 
greenhouse gases are often the major sources of air pollutants; therefore, actions aimed at 
mitigating either climate change or air pollution will likely also impact the other (e.g. 
West et al. 2004; Reynolds and Kandlikar 2008; Bollen et al. 2010; Haines et al. 2010; 
Nemet et al. 2010).  Pollution mitigation strategies may either have climate benefits or 
disbenefits, and simultaneous consideration of both issues can result in identification of 
win-win strategies that might not otherwise be recognized.  
 Outdoor air pollution is thus increasingly recognized as a global problem 
requiring international solutions (Holloway et al. 2003; Keating et al. 2004; Global 
Atmospheric Pollution Forum 2010; TF HTAP 2010).  On the national scale, 
sophisticated benefit-cost assessments have been employed to justify air pollution 
regulations, finding for example that the economic benefits of the Clean Air Act vastly 
outweigh the costs, largely due to reductions in air pollution-related mortality (US EPA 
2010).  Similar benefit-cost assessments on the global scale may be increasingly useful to 
inform domestic and international decision-making in the future (e.g. West et al. 2006).   
 
1.3. Health impact assessment 
 The relationships between pollutant levels and health outcomes identified by the 
epidemiology literature described above can be used to calculate the overall health 
impacts attributable to air pollution and changes in air pollutant concentrations. The basis 
of health impact assessment is the health impact function, which relates changes in 
pollutant concentrations to changes in the burden of disease attributable to that pollutant. 
Health impact functions take into account exposed population, baseline incidence rates, 
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pollutant concentrations, and concentration-response factors identified by the 
epidemiology literature (Figure 1.6). First, present or future population is estimated. 
Pollutant concentrations from air quality models or monitors are then used in conjunction 
with the population estimates to simulate population exposure. Finally, adverse health 
impacts are calculated using a health function, baseline incidence rates, and population 
exposure from the previous step. This method is consistent with the US Environmental 
Benefits Mapping and Analysis program (BenMAP), developed by the US EPA for 
regulatory impact analysis. 
 Health impact assessment is based on the relationships between exposure and 
health outcome (Relative Risk, RR) from the epidemiology literature. Epidemiological 
studies of O3 and PM2.5 exposure and mortality demonstrate a generally log-linear 
relationship between ambient concentrations and RR (Equation 1): 
 
  (1) 
 
Here, β is the concentration-response factor (CRF), or the slope of the line between the 
natural logarithm of ΔX, the change in concentration, and RR. Since RR=1 for unexposed 
populations, the AF is calculated by Equation 2: 
 
 
(2) 
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AF is then multiplied by the baseline mortality rate (y0) and exposed population (Pop) to 
yield the change in the health outcome resulting from the change in concentration 
(Equation 3): 
 
 (3) 
 
 Health impact assessments conducted by the US EPA focus solely on benefits 
accrued within the US, and have the benefit of highly resolved demographic and air 
quality data, including both monitored and simulated concentrations. On a global scale, 
health impact assessment must draw upon data that are substantially cruder than are 
available for just the US and are necessarily more coarsely resolved.  Some global health 
impact assessment studies have used monitored concentrations to estimate global health 
impacts of air pollution (e.g. Cohen et al. 2004). These studies are limited due to the 
sparseness of monitored concentrations around the world, particularly in developing 
countries, and the inability to examine effects of future changes in emissions and 
environmental conditions on concentrations. Using global chemical transport models 
(CTMs) to simulate exposure concentrations allows estimation of health impacts with full 
spatial coverage, not just where monitors are located. Another benefit of using CTMs for 
health impact assessment is the ability to control emissions and atmospheric conditions, 
which allows for analyzing the effects of expected or proposed changes in conditions on 
health.  
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1.4. Motivation and objectives 
 Numerous global modeling studies of the long-range transport of air pollution and 
interactions between air pollution and climate have increased awareness that air pollution 
emissions affect the environment and health on large spatial scales (e.g. TF HTAP 2010 
and references therein).  However, these studies have largely focused on impacts of 
emissions on air pollution concentrations and do not account for population exposure and 
health impacts, historically the drivers of public concern for air quality.  Prior to this 
work, few studies had used global CTMs to estimate global mortality, focusing on future 
changes in O3 (West et al. 2006; 2007), long-range transport of O3 from Europe (Duncan 
et al. 2008), emissions from shipping (Corbett et al. 2007), and air pollution changes 
associated with carbon dioxide emissions (Jacobson 2008).  In the past two years, in 
addition to the current work, global CTMs have been used to estimate mortality due to 
long-range transport of O3 and PM2.5 (Liu et al. 2009a; West et al. 2009b), future changes 
in O3 (Selin et al. 2009), aircraft emissions (Barrett et al. 2010), and fossil fuel and 
biofuel emissions (Jacobson 2010).  These studies generally support the notion that air 
pollution is not just a local problem, but affects health on regional or hemispheric scales.  
However, the body of literature examining the health impacts of air pollution on such 
large spatial scales is thin, and these studies all use different assumptions and methods, 
limiting comparability among studies.   
This dissertation is aimed at advancing understanding of the global health impacts 
of air pollution by examining different types and sources of air pollutants and the effects 
of major methodological choices on results.  Consistent with previous studies, the 
impacts of air pollution on global mortality are estimated using global CTMs to simulate 
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O3 and PM2.5 concentrations and epidemiologically-derived concentration-response 
relationships to calculate health impacts.  However, here, the previous methodology is 
improved by refining the demographic information used as inputs into the health impact 
function.  For example, country-specific baseline mortality rates are used in place of 
broad regional averages.  In addition, area-weighted average baseline mortality rates are 
used where gridcells overlap multiple countries.  Finally, this work focuses on cause-
specific mortality which is likely to be more comparable globally than all-cause 
mortality, since major causes of death vary dramatically around the world. 
These methodological improvements are employed in three case studies that 
address varied aspects of the global health impacts of air pollution, including the impacts 
of both O3 and PM2.5 and of both total anthropogenic emissions and incremental emission 
reductions.  Chapter 2 addresses the global burden of anthropogenic O3 and PM2.5 on 
premature human mortality (Anenberg et al. 2010).  Chapter 3 examines the impacts of 
intercontinental transport of O3 on mortality (Anenberg et al. 2009).  Chapter 4 considers 
the impacts of global, regional, and sectoral black carbon emissions on surface air quality 
and premature mortality (Anenberg et al. in prep).  Finally, key findings and implications 
from these case studies and future research needs are discussed in Chapter 5.  
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1.5. Tables and figures 
 
 
Figure 1.1. Concentration of smoke and sulfur dioxide and deaths per day for the London 
Smog air pollution episode of 1952.  Image source: 
http://www.ems.psu.edu/~lno/Meteo437.html 
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Figure 1.2.  Concentration-response relationships estimated from the ACS cohort of long-
term PM2.5 exposure (Pope and Dockery 2006).  
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Figure 1.3. Comparison of national levels of the six principal pollutants to national 
ambient air quality standards, 1980-2006 (US EPA 2008b).  National levels are averages 
across all sites with complete data for the time period. 
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Figure 1.4.  Springtime trends in O3 concentrations measured in remote locations in (a) 
Europe and (b) western North America and Japan (TF HTAP 2010). Abbreviations: FT = 
free troposphere; NP = national park; MBL = marine boundary layer. 
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Figure 1.5. The ―tightening vise‖ of air pollution management, shown here 
(schematically) for O3 from the perspective of an industrialized nation.  From the 
historical view to the future, air pollution managers succeed in reducing their local 
contribution to O3, and work regionally with other jurisdictions to reduce the regional 
contribution.  However, the hemispheric background increases, while their air quality 
standard becomes more stringent (Keating et al. 2004). 
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Figure 1.6.  Flow diagram of health impact assessment methodology. 
  
 
Chapter 2. An estimate of the global burden of anthropogenic ozone and fine 
particulate matter on premature human mortality using atmospheric 
modeling 
(Anenberg, S. C., Horowitz, L. W., Tong, D. Q., West, J. J. (2010). Environmental Health 
Perspectives, 118, 1189-1195.) 
 
2.1. Introduction  
 Ground-level ozone (O3) and fine particulate matter (PM2.5) have increased 
substantially since preindustrial times. While O3 and PM2.5 concentrations have increased 
most in industrialized areas, observations show that background concentrations have also 
increased in remote regions (Volz and Kley 1988; Staehelin et al. 2001; Akimoto 2003; 
Vingarzan 2004; Schulz et al. 2006). O3 and PM2.5 are associated with negative health 
impacts, including premature mortality (e.g. Jerrett et al. 2009; Krewski et al. 2009). 
Cohen et al. (2004) estimated that about 800,000 annual premature mortalities globally, 
or 1.2% of all deaths, are associated with urban outdoor PM2.5.  This was considered an 
underestimate because it excludes O3 impacts and includes only urban areas for which 
econometric models trained with observations were used to predict concentrations. 
 We estimate the global burden of human mortality due to anthropogenic O3 and 
PM2.5 using a global atmospheric chemical transport model (CTM). Using an atmospheric 
CTM allows estimation of mortality where air quality measurements are sparse, 
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particularly in developing nations. By simulating preindustrial concentrations, we also 
isolate mortality due to anthropogenic pollution and avoid making assumptions for 
background O3 and PM2.5 concentrations. Global CTMs have been used to estimate 
mortalities due to long-range transport of air pollution (Anenberg et al. 2009; Liu et al. 
2009a; West et al. 2009b), future changes in emissions (West et al. 2006; 2007), or 
changes in one sector’s emissions (Corbett et al. 2007). CTMs have not been used 
previously to quantify the global burden of anthropogenic air pollution on human 
mortality.  
 
2.2. Methods 
 We calculate mortalities associated with anthropogenic air pollution using health 
impact functions that relate changes in pollutant concentrations to changes in mortality. 
Here, we define anthropogenic air pollution as the geographically-distributed difference 
in O3 and PM2.5 concentrations between present-day (2000) and preindustrial, as 
simulated by a global chemical transport model (CTM). Health impact functions for both 
O3 and PM2.5 are based on a log-linear relationship between relative risk (RR) and 
concentrations defined by epidemiology studies (Jerrett et al. 2009; Krewski et al. 2009):  
 
RR = exp 
β ΔX
  [1] 
 
where β is the concentration-response factor (CRF) [i.e., the estimated slope of the log-
linear  relation between concentration and mortality], and ΔX is the change in 
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concentration. The fraction of the disease burden attributable to the risk factor, the 
attributable fraction (AF), is defined as: 
 
AF = (RR-1)/RR = 1 – exp - β ΔX [2] 
AF is multiplied by the baseline mortality rate (y0) and size of the exposed population 
(Pop) to yield an estimate of the excess mortalities attributable to air pollution (Δ Mort): 
 
Δ Mort = y0 (1 – exp 
–β ΔX
) Pop [3] 
 
Disease survival time varies among populations, and we calculate years of life lost (YLL) 
associated with mortalities using the baseline YLL (YLL0) per death:  
 
Δ YLL = Δ Mort * YLL0/y0  [4] 
 
Next, we describe the CRFs, simulated exposure concentrations, and demographic data 
used in the health impact functions for O3 and PM2.5. 
 For O3, we base CRFs on the association between long-term O3 exposure and RR 
of death from respiratory disease found by Jerrett et al. (2009), an American Cancer 
Society (ACS) cohort study of US adults ≥30 for 1977-2000. While many daily time-
series epidemiology studies demonstrate short-term O3-mortality impacts (e.g. Bell et al. 
2004), Jerrett et al. (2009) provides the first clear evidence for long-term impacts.  For 
the two pollutant model in which PM2.5 was controlled, a 10 part per billion (ppb) 
increase in the seasonal (April-September) average daily 1-hr maximum O3 
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(concentration range 33.3-104.0 ppb) was associated with a 4% (95% CI, 1.3%-6.7%) 
increase in RR of death from respiratory disease.  
 For PM2.5, we use RRs from Krewski et al. (2009), which is the latest reanalysis 
of the ACS PM2.5 studies (e.g. Pope et al. 2002) and has the largest population of the 
available PM2.5 cohort studies (e.g. Hoek et al. 2002; Laden et al. 2006). We use RRs for 
1999-2000 from the random effects Cox model analysis that adjusted for 44 individual-
level and seven ecological covariates. A 10 μg/m3 increase in PM2.5 (concentration range 
5.8-22.2 μg/m3), was associated with 6% (95% CI, 4%-8%), 13% (10%-16%), and 14% 
(6%-23%) increases in total, cardiopulmonary, and lung cancer mortality. The linearity of 
the concentration-response function was also demonstrated up to 30 μg/m3 in the 1979-
1983 analysis. Krewski et al. (2009) found that PM2.5 was associated most strongly with 
risk of death from ischemic heart disease, a subset of cardiopulmonary disease, and 
previous studies have found that controlling for O3 concentrations had little effect on the 
PM2.5-mortality relationships (Krewski et al. 2000). Compared with the relationships in 
an earlier expert elicitation (Roman et al. 2008), the total mortality RR in Krewski et al. 
(2009) is generally 3%-14% per 10 μg/m3 lower with a tighter confidence interval. 
 We assume that these relationships found in the US are valid globally. For O3, 
Jerrett et al. (2009) is the first study showing significant long-term impacts, but the short-
term impact has been documented well in North America and Europe (Anderson et al. 
2004; Bell et al. 2004). For PM2.5, similar long-term mortality results have been 
demonstrated in Europe (Hoek et al. 2002), but to date no PM2.5 cohort studies have been 
conducted in the developing world. Short-term O3 and PM2.5 studies in developing 
nations demonstrate relationships that are generally comparable with short-term studies in 
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North America and Europe (Health Effects Institute Scientific Oversight Committee 
2004). Our assumption is further supported by evidence that concentration-mortality 
relationships do not vary significantly by sex, age, and race (Zanobetti et al. 2000; Jerrett 
et al. 2009; Krewski et al. 2009), though some sensitive populations may be at a higher 
risk.  Because causes of death differ globally from those in North America and Europe, 
we emphasize cause-specific mortality, for which there may be less error than for 
estimates of all-cause mortality across different populations.  
 We use present day (2000) and preindustrial O3 and PM2.5 concentrations (Figure 
2.1) simulated by Horowitz (2006) using the Model of Ozone and Related Chemical 
Tracers, version 2 (MOZART-2) (Horowitz et al. 2003). The preindustrial simulation, 
which corresponds to the 1860 simulation by Horowitz (2006), represents the 
―background‖ O3 and PM2.5 present in the absence of anthropogenic emissions, allowing 
us to isolate the anthropogenic contributions to concentrations and premature mortalities. 
MOZART-2 has a resolution of 2.8º latitude by 2.8º longitude with 34 vertical levels, and 
we use concentrations in the first vertical level as surface concentrations. Both 
simulations used the same meteorology from the National Center for Atmospheric 
Research Community Climate Model to isolate the impact of emission changes on 
concentration. We define PM2.5 as all simulated sulfate (SO4), nitrate (NO3), ammonium, 
black carbon (BC), and primary organic carbon (OC). We exclude dust, sea salt, and 
secondary organic aerosols, which we assume are unchanged from preindustrial to 
present. We multiply OC mass by 1.4 to account for associated species other than carbon, 
and assume all SO4 and NO3 exists as (NH4)2SO4 and NH4NO3, following Ginoux et al. 
(2006).  For the preindustrial case, fossil fuel burning emissions were set to zero and 
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emissions from burning of biofuels, savannah, tropical forests, and agricultural waste 
were assumed to be 10% of 1990 values.  
 Consistent with the epidemiology studies, we use seasonal average 1-hr daily 
maximum concentrations for O3 and annual average concentrations for PM2.5. Because 
high O3 occurs during different months globally, for each grid cell, we find the 
consecutive 6-month period with the highest average of the simulated daily 1-hr 
maximum O3 concentrations, which we then use to calculate annual mortalities.  Table 
2.1 shows that the modeled global population-weighted seasonal average 1-hr. daily 
maximum O3 increased by 37.1 ppb (from 19.6 ppb in 1860 to 56.7 ppb in 2000), using 
present population, and the global population-weighted annual average PM2.5 increased 
by 15.0 µg/m
3
 (from 1.1 µg/m
3
 in 1860 to 16.1 µg/m
3
 in 2000). Globally, OC, BC, NO3, 
and SO4 are 62.3%, 6.3%, 0.3%, and 31.0% of total PM2.5 in 1860 and 45.6%, 9.1%, 
4.9%, and 40.4%  in 2000 (see Figure A.1). 
 We compare modeled present day surface O3 concentrations with the Climate 
Monitoring and Diagnostics Laboratory (CMDL; http://www.esrl.noaa.gov/gmd/) 
monitoring network (mean bias=2.5ppb) for 11 remote locations around the world, and 
for three non-urban networks: the Clean Air Status and Trends Network (CASTNet; 
https://www.epa.gov/castnet/index.html) for the US (mean bias=2.9ppb), the European 
Monitoring and Evaluation Programme (EMEP; http://www.emep.int/) for Europe (mean 
bias=-0.2ppb), and the Acid Deposition Monitoring Network in East Asia (EANET; 
http://www.eanet.cc/) for Japan (mean bias=0.4ppb) (see Figure A.2-Figure A.5). 
Horowitz (2006) found that simulated preindustrial O3 concentrations overestimate 
reconstructed observations from the late nineteenth century by ~5-10 ppb, with strong 
  
27 
 
sensitivity to assumed biomass burning. Modeled surface PM2.5 concentrations were 
compared with observations by Ginoux et al. (2006) and were generally found to be 
estimated within a factor of 2 in remote locations and at non-urban stations in Europe and 
the US, with a tendency to be overestimated. These comparisons show that surface O3 
and PM2.5 are simulated well by MOZART-2 for non-urban and remote measurements in 
the areas compared, and it is not apparent that corrections for bias are necessary. While 
simulated concentrations are not systematically biased outside of urban regions, the 
coarse resolution (grid cell area=9.9x10
4
, 8.6x10
4
, and 5.2x10
4
 km
2
 at 0°, 30°, and 60° 
latitude) used here may cause errors in mortality estimates, particularly in urban areas 
with strong population and concentration gradients.  
 Global premature mortalities are estimated separately for O3 and PM2.5 by 
applying Equation 3 in each of the MOZART-2 surface grid cells, using the 
corresponding population and baseline mortality rates for each cell.  We use the global 
2006 population (see Figure A.6) (Oak Ridge National Laboratory 2008), and, consistent 
with the ACS study population, the population fraction ≥30 (Table 2.1), estimated in 14 
world regions (see Figure A.7) (World Health Organization 2004), to calculate mortality. 
We use baseline all-cause, cardiopulmonary, and lung cancer mortality rates for 14 world 
regions (World Health Organization 2004) and 66 countries (World Health Organization 
2008b), back-calculating from regional rates where country-specific rates are unavailable 
(Table 2.1 and Figure A.8-Figure A.11). Country-specific mortality rates are broadly 
categorized with no cutoff at age 30, and we use rates for the population ≥25, assuming 
that differences between the rates are insignificant. We use baseline YLL rates for the 
population ≥30 in 14 world regions (global average=7.89, 9.77, and 8.93 for 
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cardiopulmonary disease, respiratory disease, and lung cancer; see Table A.1), assuming 
a 3% discount rate and non-uniform age-weighting, giving less weight to years lived at 
older ages (World Health Organization 2008b). Baseline mortality rates, baseline YLL, 
and the fraction of the population ≥30 are gridded to the MOZART-2 grid, and for grid 
cells overlapping multiple countries, we calculate area-weighted averages using a 
Geographic Information System (GIS) program.  
 We present mean results ± 1 standard deviation, calculating uncertainty from 500 
Monte Carlo simulations that randomly sample from normal distributions of the CRF, as 
reported by the epidemiology studies, and modeled present-day concentrations (standard 
deviation=25% of simulated value). While the epidemiology literature provides little 
evidence for low-concentration (LCT) or high-concentration thresholds (HCT) for either 
O3 or PM2.5 (Schwartz and Zanobetti 2000; Jerrett et al. 2009; Krewski et al. 2009), 
mortality relationships beyond measured concentrations are unknown. Therefore, we 
estimate mortalities with and without assuming LCTs below which O3 and PM2.5 are 
assumed to have no effect on mortality. For O3, we apply an LCT of 33.3 ppb, the lowest 
measured level in Jerrett et al. (2009). When applied, this threshold replaces the natural 
background everywhere except in some grid cells in Asia and South America, where 
preindustrial concentrations exceed the threshold (Table 2.1). We also examine an LCT 
of 56 ppb, which Jerrett et al. (2009) found to be close to statistical significance at an α-
level of 5% (p=0.0600). The 56 ppb threshold exceeds preindustrial concentrations in all 
cells. Since no grid cells exceed the highest measured level (104.0 ppb) in Jerrett et al. 
(2009), we do not apply an HCT for O3. For PM2.5, we apply an LCT of 5.8 μg/m
3
, the 
lowest measured level in Krewski et al. (2009), which exceeds preindustrial 
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concentrations in all grid cells (Table 2.1), effectively replacing the natural background. 
Some grid cells in Europe and Asia exceed the highest measured level (30.0 μg/m3) in 
Krewski et al. (2009), and we examine HCTs of 30 μg/m3 and 50 μg/m3 in the sensitivity 
analysis. These thresholds apply only to our definition of PM2.5 and would be affected by 
including dust, sea salt, and secondary organic aerosols. 
 
2.3. Results 
  With no upper or lower concentration threshold, anthropogenic O3 is estimated to 
result in about 0.7 ± 0.3 million respiratory mortalities annually worldwide (Table 2.2), 
corresponding to 6.3 ± 3.0 million YLL (Table 2.3). Estimated global respiratory 
mortalities are reduced by ~33% when we assume an LCT of 33.3 ppb, the lowest 
measured level in Jerrett et al. (2009). Regardless of threshold assumption, over 75% of 
O3 mortalities are estimated to occur in Asia, which is densely populated and highly 
polluted, while only ~5% occur in North America. Estimated excess O3 mortalities are 
most dense in highly populated areas, but are distributed more evenly across the globe 
when divided (normalized) by population size (Figure 2.2).  
 Assuming no upper or lower concentration threshold, we estimate that exposure to 
anthropogenic PM2.5 results in 3.5 ± 0.9 million cardiopulmonary mortalities and 220,000 
± 80,000 lung cancer mortalities annually (Table 2.2), corresponding to 28 ± 6.8 and 2.2 
± 0.8  million YLL (Table 2.3). With an LCT of 5.8 μg/m3, estimated cardiopulmonary 
and lung cancer mortalities decrease by ~28%. Regardless of threshold, about 75% of 
excess mortalities would occur in Asia, due to high PM2.5 concentrations and dense 
population, followed by Europe (17%). As for O3, estimated PM2.5 mortalities are most 
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dense in highly populated areas, but are more localized due to the shorter atmospheric 
lifetime of PM2.5 vs. O3 (Figure 2.1 and Figure 2.3). The highest estimated rates of 
mortalities per million people are in Europe, East Asia, and the Eastern US (Figure 2.3, 
right), owing to large baseline cardiopulmonary and lung cancer mortality rates and high 
PM2.5 concentrations. 
 Applying an LCT of 25 ppb for O3 results in ~14% fewer estimated respiratory 
mortalities compared with the estimate assuming no upper or lower threshold (Table 2.4). 
Using CRFs from the single-pollutant model in Jerrett et al. (2009), which did not control 
for PM2.5, O3 mortality estimates are ~25% lower, corresponding to the relative 
magnitudes of the CRFs. Applying the 56 ppb LCT from the threshold model reduces 
mortality estimates by ~75%. For PM2.5, RRs from Krewski et al. (2009) are similar to 
the 1979-1983 and 1999-2000 average all-cause and lung cancer RRs from Pope et al. 
(2002), but are ~40% higher for cardiopulmonary mortality, thus causing a corresponding 
increase in our estimates when applied (Table 2.5 and Table A.2). Using RRs from Laden 
et al. (2006), an extended reanalysis of the Harvard Six Cities cohort study that found 
significantly higher RRs than did Krewski et al. (2009), increases estimated 
cardiopulmonary and lung cancer mortalities by ~30% and 50%. With no LCT, applying 
HCTs of 30 µg/m
3
 and 50 µg/m
3 
decreases estimated mortalities by ~10% and 1%, with 
larger decreases estimated for Europe and Asia where some modeled concentrations 
exceeded the upper threshold values.  
 
  
31 
 
2.4. Discussion and Conclusions 
 We estimate the global burden of mortality due to anthropogenic O3 and PM2.5 
using a global atmospheric chemical transport model and health impact functions. 
Anthropogenic O3 is associated with about 0.7 ± 0.3 million respiratory mortalities (1.1% 
± 0.5% of all mortalities) and 6.3 ± 3.0 million YLL annually when no upper or lower 
concentration threshold is assumed. Anthropogenic PM2.5 is associated with about 3.5 ± 
0.9 million cardiopulmonary (5.6% ± 1.4% of all mortalities) and 220,000 ± 80,000 lung 
cancer mortalities (0.4% ± 0.1% of all mortalities) annually when no threshold is 
assumed, corresponding to 30 ± 7.6 million YLL. Global mortalities were reduced by 
~30% when we assumed low-concentration thresholds of 33.3 ppb for O3 and 5.8 μg/m
3
 
for PM2.5, the lowest measured levels in Jerrett et al. (2009) and Krewski et al. (2009). 
Estimated excess mortalities are most dense in highly populated areas, but also occur in 
rural areas that have been affected by the increased regional or global background of air 
pollution since preindustrial times. These estimates based only on cardiopulmonary and 
lung cancer mortality may be conservative since O3 and PM2.5 may also affect other 
causes of mortality.  In addition, to be consistent with the ACS study population, we 
included only the population ≥30, but evidence suggests that O3 and PM2.5 affect health 
negatively for all ages, including the very young (US EPA 2008a and references therein).  
 Estimated PM2.5 mortalities are five times O3 mortalities, suggesting PM2.5 is the 
dominant contributor to the global health burden of outdoor air pollution. To minimize 
double counting of mortalities, we applied long-term RRs for O3 and PM2.5 based on the 
same ACS cohort. PM2.5 RRs have been shown previously to be independent from O3 
concentrations (Krewski et al. 2000), and we use O3 RRs from Jerrett et al. (2009)  that 
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control for PM2.5. Furthermore, Jerrett et al. (2009) and Krewski et al. (2009) reported 
that PM2.5-related mortality was dominated by cardiovascular mortality, while O3 was 
primarily associated with respiratory mortality. The independence of the exposure-
response relationships and difference in dominant biological mechanisms of mortality for 
each pollutant implies that double counting is unlikely to be significant. If these 
implications are correct, O3 and PM2.5 mortalities may be summed together to yield total 
mortalities; otherwise, summing the results would overestimate total mortalities.  
 Mortality estimates were sensitive to concentration thresholds and concentration-
mortality relationships, often changing by more than 50% of the estimated value under 
different assumptions. We assume that the CRFs found by epidemiology studies 
conducted in North America apply globally, despite differences in health status, lifestyle, 
age structure, and medical care, and emphasize cause-specific mortality. The CRFs used 
here could also be subject to confounders, including temperature (Jerrett et al. 2009). 
Although some evidence suggests differential toxicity of PM2.5 components (Franklin et 
al. 2008; Ostro et al. 2008), we assume that all PM2.5 species exert effects similar to 
aggregated PM2.5, despite differences in PM2.5 composition throughout the world. These 
assumptions, while necessary due to limited data, may have substantial impacts on the 
results.   
 Using the same assumptions for CRFs (Pope et al. (2002) for 1979-1983) and 
low-concentration threshold (7.5 μg/m3, applied to total PM2.5 in Cohen et al. (2004), but 
here only to the species in our definition of PM2.5), our mortality estimates for urban and 
rural areas (Table 2.5) are ~50% higher than the previous estimate of 800,000 mortalities 
from urban air pollution reported by Cohen et al. (2004). The discrepancy results from 
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two competing differences in methods.  First, we include rural populations, which were 
excluded by Cohen et al. (2004). Because the urban population in Cohen et al. (2004) is 
~30% of the total global population, and air pollution has increased in rural regions, 
inclusion of rural populations suggests many more air pollution mortalities globally. 
Second, we use a coarse resolution global CTM that spreads emissions across large grid 
cells. While rural O3 and PM2.5 are simulated well, the coarse resolution may suppress 
high urban PM2.5 concentrations, causing us to underestimate PM2.5 mortalities. 
Compared with a previous US estimate of 144,000 PM2.5 mortalities (all causes) found 
using a regional CTM (US EPA 2009), our estimate of PM2.5 mortalities in North 
America is similar but slightly lower (by 2% for cardiopulmonary and lung cancer 
mortalities and 7% for all cause mortalities). The coarse resolution model may either 
overestimate or underestimate O3 pollution in urban areas, as O3 precursors are diluted 
into a large volume. Previous studies have found that regional O3 can be overestimated by 
13% at the resolution used here, but that background concentrations are not greatly 
affected by resolution (Wild and Prather 2006). A finer resolution model would capture 
urban populations and concentrations more accurately, but adequate resolution is not 
currently possible in global air quality models.   
 Despite these limitations, this study highlights regions where improvements to air 
quality may be particularly effective at reducing air pollution-related mortality. Previous 
estimates rank urban air pollution (PM2.5 only) as the 13
th
 leading global risk factor and 
3
rd
 among environmental risks (Ezzati et al. 1999). Our results suggest a larger burden of 
disease due to outdoor air pollution than was previously estimated, but should only be 
compared with other risk factors when all are updated consistently. Future estimates of 
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the global burden of air pollution on mortality should strive to combine information from 
global and regional models with rural and urban concentrations from measurements. 
CRFs from new studies on O3 and PM2.5 mortality relationships that examine individual 
PM2.5 components, that are conducted in different parts of the world, that include 
populations of all ages, and that resolve relationships at low and high concentrations 
should also be incorporated. In the future, global economic development will likely shift 
the disease burden from infectious disease and malnutrition to chronic conditions, which 
are more strongly affected by air pollution exposure. While some countries have 
implemented policies to improve air quality, without further action, the global burden of 
anthropogenic air pollution on mortality may be even larger in the future than is 
estimated for the present.  
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2.5. Tables and figures 
Table 2.1. Population ≥30, average baseline mortality rates (Resp.=respiratory, CP=cardiopulmonary, LC=lung cancer), and 
population-weighted average and range (below, shown for the highest and lowest individual grid cells) of the seasonal average 
(6-month) 1-hr. daily maximum O3 concentrations and annual average PM2.5 concentrations from MOZART-2 simulations of 
the preindustrial (1860) and present (2000) (Horowitz 2006). 
 
Abbreviations: CP, cardiopulmonary; LC, lung cancer; Pop, population. Data are average and range for the highest and lowest 
individual grid cell. 
a
Simulated by Horowitz (2006). 
b
Population ≥ 30 years of age for the year 2006 from the Landscan database (Oak Ridge 
National Laboratory 2008). 
c
Baseline mortality rates are country-specific for the latest year after 2000 where data were 
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available (World Health Organization 2008b). Where country-specific rates after the year 2000 were not available, we back-
calculate country-specific rates from regional rates for the year 2002. 
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Table 2.2.  Annual estimated mortalities ± 1 SD due to anthropogenic O3 and PM2.5, assuming natural background only or 
LCTs (33.3 ppb for O3 and 5.8 µg/m
3
 for PM2.5) (x1000). 
 
SDs reflect uncertainty in the CRF and simulated present-day concentrations (SD=25% of simulated concentration). 
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Table 2.3.  Estimated annual YLL ± 1 SD due to anthropogenic O3 and PM2.5, assuming natural background or LCTs (33.3 ppb 
for O3 and 5.8 µg/m
3
 for PM2.5) (x1000).  
 
SDs reflect uncertainty in the CRF and simulated present-day concentrations (SD=25% of simulated concentration)
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Table 2.4.  Estimated annual global O3 mortalities (mean ± 1 SD) to CRFs from the multipollutant model (in which PM2.5 was 
controlled) and single-pollutant model in Jerrett et al. (2009), and LCTs (x1000). 
 
Data in parentheses are percentage change from estimates assuming CRFs from Jerrett et al. (2009) multipollutant model with 
no LCT (top row).  Uncertainty is from the CRF and simulated present-day concentrations (SD=25% of simulated 
concentration).  
a
Calculated using the CRF (0.00432 ppb
-1
) and corresponding standard error (0.00121 ppb
-1
) for respiratory mortality when a 
threshold of 56 ppb is included in the O3-mortality model (Jerrett et al. 2009). Although Jerrett et al. (2009) found that no 
threshold model was clearly a better fit to the data than a linear representation of the overall O3-mortality association, a 
threshold of 56 ppb was close to statistical significance (p=0.06).
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Table 2.5.  Estimated annual global PM2.5 mortalities (mean ± 1 SD) using alternative CRFs with and without LCTs and HCTs 
(x1000).  
 
Data in parentheses are percentage change from estimates using CRFs from Krewski et al. (2009) and no LCT or HCT (top 
row).  Uncertainty is from the CRF and simulated present-day concentrations (SD=25% of simulated concentration). 
a
 Pope et al. (2002) reported RR estimates for two time periods (1979-1983 and 1999-2000) and for the integrated average of 
both. The RR estimates for 1979-1983 were more conservative than those from 1999-2000 and the integrated average. See 
Table A.2 for results from the average of both time periods and with concentration thresholds. 
b
 Laden et al. (2006) extended the follow-up of the Harvard Six Cities adult cohort study for 8 years, finding significantly 
higher RR estimates for overall mortality than the original study and Krewski et al. (2009). See Table A.2 for results with 
concentration thresholds.
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Figure 2.1.  Estimated change (present minus preindustrial) in (A) seasonal average (6-
month) 1-hr. daily maximum O3 concentrations (ppb) and (B) annual average PM2.5  
(µg/m
3
) from Horowitz (2006) simulations. 
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Figure 2.2.  Estimated annual premature respiratory mortalities attributed to 
anthropogenic O3 when no threshold is assumed, for respiratory mortalities (A) per 1000 
km
2
 and (B) per 10
6
 people. 
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Figure 2.3.  Estimated annual premature mortalities attributed to anthropogenic PM2.5 
when no upper or lower concentration threshold is assumed, for (A) cardiopulmonary 
mortalities per 1000 km
2
, (B) rate of cardiopulmonary mortalities per 10
6
 people, (C) 
lung cancer mortalities per 1000 km
2
, and (D) rate of lung cancer mortalities per 10
6
 
people. 
 
 
  
 
Chapter 3. Intercontinental impacts of ozone pollution on human mortality 
(Anenberg, S. C., West, J. J., Fiore, A. M., Jaffe, D. A., Prather, M. J., Bergmann, D., 
Cuvelier, K., Dentener, F. J., Duncan, B. N., Gauss, M., Hess, P., Jonson, J.- E., Lupu, 
A., MacKenzie, I. A., Marmer, E., Park, R. J., Sanderson, M. G., Schultz, M., Shindell, 
D. T., Szopa, S., Vivanco, M. G., Wild, O., and G. Zeng. (2009). Environmental Science 
and Technology, 43, 6482-6487.) 
3.1. Introduction 
 Ground-level ozone (O3) causes deleterious impacts to human health, including 
cardiovascular and respiratory mortality (Bell et al. 2004; Bell et al. 2005; Ito et al. 2005; 
Levy et al. 2005).  O3 is photochemically produced in the troposphere by oxidation of 
methane (CH4), non-methane volatile organic compounds (NMVOCs), and carbon 
monoxide (CO) in the presence of nitrogen oxides (NOx = NO + NO2). Observations and 
modeling studies demonstrate that O3 produced in polluted regions can be transported 
long distances and that transport of precursors can enhance O3 production in remote 
regions, impacting air quality on a global scale (TF HTAP 2007; Fiore et al. 2009). 
Understanding the impacts of O3 precursor emissions from one region on health in distant 
regions may inform future air pollution mitigation strategies. 
 The impacts of O3 on human mortality are influenced by demographic 
characteristics, including population density and baseline mortality rates. We calculate 
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the premature mortalities within the entire Northern Hemisphere (NH) and within four 
major industrial regions – North America (NA), East Asia (EA), South Asia (SA), and 
Europe (EU) – that could be avoided by decreasing O3 precursor emissions in each 
region. We use results from the Task Force on Hemispheric Transport of Air Pollution 
(TF HTAP, www.htap.org) multi-model study which showed that surface O3 in one 
region decreases following 20% reductions of anthropogenic NOx, NMVOCs, and CO 
emissions in any of the foreign regions, and that the O3 decrease is similar to that from a 
20% reduction in anthropogenic CH4 emissions in the same foreign region (TF HTAP 
2007; Fiore et al. 2009). We estimate avoided premature mortalities using these simulated 
long-range O3 responses and a health impact function. 
 
3.2. Methods 
 The TF HTAP coordinated an effort to quantify source-receptor relationships for 
four regions (NA, EA, SA, and EU; Figure B.1), using multiple chemical transport 
models (CTMs) (Fiore et al. 2009). We use the resulting multi-model mean surface O3 
responses for 20% reductions in NOx, NMVOC, and CO emissions in each region (SR6) 
and a 20% reduction in the global CH4 mixing ratio (SR2), relative to the base case 
(SR1). Fourteen models participated in the SR6 vs. SR1 cases and 17 models in the SR2 
vs. SR1 case, all with horizontal resolution ranging from 5° x 5° to 1° x 1° (Table B.1), 
meteorology and emissions from 2001, and a constant CH4 mixing ratio (1760 ppb for 
base case). All models have fixed meteorology, and do not model changes in 
meteorology due to atmospheric composition. For the 20% reductions in NOx, NMVOC, 
and CO emissions, we do not account for long-term changes in O3 due to the resulting 
  
46 
 
change in CH4 (Wild et al. 2001; West et al. 2007; Fiore et al. 2009), which is estimated 
to be small for this scenario.  Compared with surface O3 observations, the model 
ensemble mean captured seasonal cycles in the northern mid-latitude regions, except for a 
10-20 ppb summertime positive bias over the eastern United States (US) and Japan, 
which did not correlate with estimates of the O3 response to foreign emission reductions. 
Surface O3 concentrations (monthly averages) from the individual models are regridded 
to a common 0.5° x 0.5° grid, and the ensemble average concentration is calculated for 
each grid cell and perturbation scenario.  
 Following previous studies using one global CTM (West et al. 2006; Corbett et al. 
2007; Duncan et al. 2008; West et al. 2009b), avoided premature mortalities resulting 
from each perturbation scenario are calculated using a health impact function based on a 
log-linear relationship between O3 concentration and relative risk (RR) (Bell et al. 2004). 
RR is used to calculate the attributable fraction (AF), the fraction of the disease burden 
attributable to the risk factor (Equation 1). When RR>1, O3 exposure increases risk of 
mortality. 
 
Equation (1)     
 
Here, β is the concentration-response factor (CRF) and ΔX is the change in O3 
concentration. AF is multiplied by the baseline mortality rate (y0) and exposed population 
(Pop) to yield avoided mortalities due to the O3 concentration change (Equation 2). 
 
Equation (2)          ∆ Mort = y0 (1 – exp 
–β∆X
) Pop 
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 We apply Equation 2 in each grid cell for each month using the corresponding 
population and baseline mortality rates, and sum the results to yield annual avoided 
premature mortalities (―avoided mortalities‖).  
 CRFs are from a daily time-series study of the average relative risk of mortality 
associated with short-term ambient O3 concentrations in 95 US cities (Bell et al. 2004). 
For each 10 ppb increase in 24-hr. average O3, total non-accidental (includes 
cardiovascular and respiratory) mortality increased by 0.52% (95% posterior interval 
(PI), 0.27%-0.77%) and cardiovascular and respiratory mortality in particular increased 
by 0.64% (95% PI, 0.31%-0.98%). These values are relatively low compared with other 
studies in the US (Ostro et al. 2006), and we assume that they are valid globally, as 
similar results have been demonstrated in Europe and in developing nations (Health 
Effects Institute Scientific Oversight Committee 2004; Ostro et al. 2006). Compared with 
estimates of avoided non-accidental mortalities, estimates of avoided cardiopulmonary 
mortalities may be less influenced by differences in mortality causes around the world. 
We present results for both cardiopulmonary and non-accidental mortalities, but 
emphasize the cardiopulmonary results, which alone may underestimate the impact of 
decreased O3 on mortality by excluding other causes of death potentially associated with 
O3.  
 Epidemiology studies relating O3 and mortality may be subject to confounding by 
correlated co-pollutants, weather, and other factors, such as demographics and health 
status. As recommended previously (National Academy of Sciences 2008), we use data 
from Bell et al. (2004), who controlled for known confounders, and examine the 
sensitivity of our results to RR estimates from meta-analyses of single-city time-series 
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studies (Bell et al. 2005; Ito et al. 2005; Levy et al. 2005). While little evidence exists for 
a low-concentration threshold below which O3 causes no adverse impacts (National 
Academy of Sciences 2008), we calculate results with and without a low-concentration 
threshold of 35 ppb, as recommended for European analyses (Holland et al. 2005).  
 We map the gridded global population in 2006 (Oak Ridge National Laboratory 
2008; NH total is 5.71 billion) to the coarser grid of the multi-model mean O3 
concentrations. Baseline cardiopulmonary and non-accidental mortality rates are from the 
World Health Organization for 14 world regions (World Health Organization 2004) and 
66 countries (World Health Organization 2008b). For countries with no available data, 
we back-calculate population-weighted average mortality rates from regional rates. We 
use a Geographic Information System to calculate area-weighted average rates for grid 
cells that overlap multiple countries and to calculate avoided mortalities within US 
borders.  
 Our estimates of O3 responses are subject to uncertainty due to the coarse 
resolution of global models. While global models are currently necessary to estimate 
long-range transport, their coarse resolution influences O3 production within the source 
region, and our results may differ from those of a fine-resolution regional model. Errors 
due to resolution are expected to be smaller for long-range transport, as changes in 
concentration are more spatially uniform (Wild et al. 2006). Errors for mortality estimates 
may be greatest within source regions, particularly in urban regions with strong 
population gradients. 
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3.3. Results 
3.3.1. Regional NOx, NMVOC, and CO emission reductions 
 For simultaneous 20% reductions of anthropogenic NOx, NMVOC, and CO 
emissions in each of the four regions, the largest impact on the multi-model mean change 
in surface O3 occurs in the ―domestic‖ region (i.e. where emissions are reduced) (Table 
3.1). We note that ―domestic‖ impacts include transport between metropolitan regions, 
states, and neighboring nations. Emission reductions in SA yield the greatest disparity 
between the domestic and ―foreign‖ (i.e. within the three regions outside of the source 
region) population-weighted O3 response, with a ratio of the domestic change to the 
change in each foreign region of 17-32. EA emission reductions also cause a large 
domestic vs. foreign difference (ratio of domestic to foreign response of 6.5-8.2), while 
this ratio is smaller for NA (2.8-6.4) and EU (2.7-3.9).  
 Regardless of where emission reductions occur, avoided mortalities are 
concentrated in highly populated areas (e.g. Northern India and China; Figure 3.1, left). 
The greatest rates of avoided mortalities per million people occur near the source region 
(Figure 3.1, right), except for EU, where NOx reductions increase O3 during the winter 
(Fiore et al. 2009), increasing domestic mortalities. For each receptor region, reducing 
domestic emissions is more effective at decreasing mortalities than reducing emissions in 
any of the three foreign regions (Table 3.2 and Table B.2). In response to domestic 
emission reductions, more avoided mortalities are calculated in EU with a threshold than 
without, since the wintertime domestic mortality increase often occurs when O3 
concentrations are lower than 35 ppb.  
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 Reducing anthropogenic precursor emissions by 20% in all regions together 
avoids 21,800 (95% confidence interval (CI), 10,600-33,400) cardiopulmonary 
mortalities in the NH annually, assuming no threshold (Table 3.2), corresponding to 
about 6% of global cardiopulmonary mortalities attributable to O3 (Anenberg et al. 2010) 
and about 0.03% of mortalities of all causes globally. Avoided non-accidental mortalities 
are about 1.7 times higher than the cardiopulmonary results (Table B.2). Foreign 
emission reductions contribute about 30% of the total avoided mortalities in NA (63-72% 
of these in the US) and EA, 20% for SA, and >50% for EU, indicating that more 
mortalities would be avoided in EU by reducing emissions in the three foreign regions 
compared with reducing domestic emissions. 
 Focusing on the impacts of each source region, 64-76% of the total annual NH 
avoided mortalities following NA emission reductions occur outside of NA (the range 
reflects different causes of mortality and threshold assumptions). Without a threshold, 55-
58% of the total annual NH avoided mortalities following EU emission reductions occur 
outside of EU, though this conclusion reverses when a threshold of 35 ppb is applied (38-
40% outside of EU). These findings agree with recent studies indicating that emission 
reductions in NA and EU have greater impacts on mortality outside the source region 
than within (Duncan et al. 2008; West et al. 2009b). NA is the only region where 
reducing emissions avoids more mortalities in a foreign receptor region (EU) than 
domestically, reflecting higher population and baseline mortality rates in EU. However, 
this conclusion does not hold when a threshold is applied (Table 3.2 and Table B.2). 
Emission reductions in SA yield the most annual avoided mortalities overall, but 
influence foreign regions the least, (90% of the resulting NH avoided mortalities are in 
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SA) due to its large population and minor influence of emissions on O3 in the three 
foreign regions (Table 3.1). Emission reductions in EA also result in more avoided 
mortalities within the region (about 70% of the total NH avoided mortalities) than in the 
rest of the NH. 
 We analyze the sensitivity of the avoided non-accidental mortality results to the 
uncertainty in the O3 responses simulated by the model ensemble for each grid cell (Table 
B.3 and Figure 3.2). Different resolutions, O3 precursor emissions, and representations of 
chemical and transport processes in the individual models contribute to a large standard 
deviation among O3 responses, particularly within the source region (Fiore et al. 2009).  
The range of avoided mortalities given by the 68% CI (± 1 standard deviation) in the 
modeled O3 responses is similar in magnitude to the 95% CI in the CRF from Bell et al. 
(2004) for foreign source-receptor pairs, but is larger for each region in response to 
domestic emission reductions, except for SA. This large range in O3 response to domestic 
emission reductions influences the relative importance of source-receptor pairs for 
mortality. For example, whereas using the ensemble mean O3 concentration for NA 
emission reductions results in similar annual avoided mortalities in NA and EU, using the 
mean minus 1 standard deviation leads to more avoided mortalities in EU than in NA, 
and using the mean plus 1 standard deviation leads to more avoided mortalities in NA 
than in EU (Table B.3). A similar effect occurs for foreign vs. domestic avoided 
mortalities from EU emission reductions. 
 We also examine the sensitivity of the avoided non-accidental mortalities to the 
mean CRF from three meta-analyses of single-city daily time-series studies (Table B.3 
and Figure 3.2), which have generally consistent results (Bell et al. 2005; Ito et al. 2005; 
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Levy et al. 2005) and do not report CRFs for cardiopulmonary mortalities. The mean 
CRF from the meta-analyses is larger than the CRF from Bell et al. (2004); consequently, 
avoided mortality estimates are 1.6-1.9 times larger. While the range in modeled O3 
responses to emission changes contributes more to uncertainty in our estimated avoided 
mortalities than does the uncertainty associated with the CRF from Bell et al. (2004) for 
some regions, using the mean CRF from the meta-analyses yields avoided mortality 
estimates that are often near or higher than the upper end of the range from the 
uncertainty in modeled O3 concentrations (Figure 3.2). Therefore, source-receptor 
relationships for mortality are highly sensitive to both the CRF and modeled O3 responses 
to emission reductions. 
 
3.3.2. Global CH4 mixing ratio reduction 
 Reducing the global CH4 mixing ratio by 20% decreases O3 fairly uniformly around 
the world, so that the population-weighted changes in O3 concentration in all receptor 
regions are comparable and slightly higher in SA and EU (  
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Table 3.3), in agreement with previous studies (West et al. 2006; West et al. 2007; Fiore 
et al. 2008). About 80% of the 16,000 (95% CI, 7,700-24,400) NH annual avoided 
cardiopulmonary mortalities (assuming no concentration threshold) occur in the four 
regions, 8% of which occur in NA (57-82% of these in the US), 28% in EA, 35% in SA, 
and 29% in EU. Since the concentration change in each region is similar, the differences 
in avoided mortalities are largely driven by population and baseline mortality rates. 
Avoided non-accidental mortalities are about 1.7 times the cardiopulmonary results, and 
both are 0.6-0.8 times the results with a threshold of 35 ppb (Table B.4).  These results 
are similar to a previous estimate of about 30,000 avoided non-accidental mortalities in 
2030 due to 20% global anthropogenic CH4 emission reductions (West et al. 2006), when 
accounting for differences in steady-state assumptions, modeled CH4 reductions, and 
future population growth. CH4 responds to emission reductions over decades, during 
which population growth increases the ultimate health benefits of CH4 reductions. 
 Following methods used by Fiore et al. (2009), we infer the contribution of 20% 
anthropogenic CH4 emission reductions in each region to the simulated O3 response from 
reducing the global CH4 mixing ratio by 20% (see Appendix B). We find about 
equivalent resulting reductions in population-weighted O3 concentrations and avoided 
mortalities in the NH (Table 3.4), with the greatest mortality decrease in SA and smallest 
in NA (Figure B.5). Without a threshold, reducing anthropogenic CH4 emissions by 20% 
in all source regions collectively avoids 8,600 (4,100-13,100) cardiopulmonary 
mortalities annually. Avoided non-accidental mortalities are about 1.7 times the 
cardiopulmonary results, and both are about 0.7 times the results with a threshold of 35 
ppb (Table B.5). The domestic impacts of reducing regional CH4 emissions are 0.1-0.3 
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times those from reducing domestic NOx, NMVOC, and CO emissions by the same 
percentage, due to the large domestic effects of these precursors (Table 3.2 and Figure 
B.5). However, for each region, reducing emissions of NOx, NMVOC, and CO in the 
three foreign regions has similar impacts on mortality as an equivalent percentage 
decrease in CH4 emissions (Table 3.2 and Figure B.5). 
 
3.3.3. Foreign vs. domestic influences within North America 
 Foreign anthropogenic NOx, NMVOC, and CO emission reductions decrease 
mortalities in NA throughout the year, but compared with domestic emission reductions, 
cause fewer avoided mortalities in the summer and more in the winter due to the 
seasonality of O3 in response to domestic NOx emission reductions (Figure 3.3 and Figure 
B.6). We compare foreign and domestic impacts in NA using Health Import Sensitivity 
(HIS), the ratio of the summed avoided mortalities following NOx, NMVOC, and CO 
emission reductions in the three foreign regions to the avoided mortalities following 
emission reductions in NA only. When HIS<1, the avoided mortalities due to domestic 
emission reductions are greater than the sum of those from emission reductions in the 
three foreign regions. The annual HIS for NA is 0.56, indicating that reducing domestic 
emissions is more effective than reducing foreign emissions for avoiding mortalities. The 
HIS for NA is lowest in the summer due to the large influence of domestic vs. foreign 
emissions on mortality and approaches infinity in the winter, when foreign emission 
reductions decrease O3 but domestic emission reductions increase O3 (Figure 3.3).  
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3.4. Discussion  
 We estimate the intercontinental impacts of O3 on human mortality using a health 
impact function and multi-model estimates of the surface O3 response to precursor 
emission reductions in four large industrial regions. Reducing O3 precursor emissions by 
20% within each receptor region (―domestic‖) avoids more mortalities than does reducing 
emissions in any of the three foreign regions. However, for all regions, emission 
reductions in the three foreign regions contribute significantly to the avoided mortalities 
resulting from emission reductions in all regions combined (30% for NA and EA, 20% 
for SA, and >50% for EU). For EU, the larger foreign impact is due to the influence of 
NA emissions.  
 Intercontinental health impacts of O3 are influenced by the contribution of foreign 
emissions to O3 in each region and by regional population and baseline mortality rates. 
Using the mean O3 responses from the multi-model ensemble, more mortalities are 
avoided outside the source region than within following emission reductions in NA (64-
76% of resulting NH annual avoided mortalities occur outside the source region) and EU 
(55-58%, assuming no threshold). The opposite is true for EA (about 70% within the 
source region) and SA (about 90%). Due to large populations, reducing emissions in any 
of the regions avoids many mortalities in EA and SA. Similarly, lowering the global CH4 
abundance by 20% reduces mortality most in SA, followed by EU, EA, and NA.  
 The relative importance of source-receptor pairs for mortality is strongly 
influenced by the accuracy and consistency of global CTMs in estimating O3 responses to 
domestic and foreign precursor emission reductions. The substantial inter-model 
variation, particularly in the domestic O3 response, causes uncertainty that influences our 
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conclusions about the relative numbers of domestic vs. foreign avoided mortalities. We 
expect that the coarse resolution of global models captures long-range transport, but may 
cause error particularly for domestic emission reductions. In assessing mortalities, 
systematic positive biases in the model ensemble mean O3 should not affect our results 
when no threshold is assumed, but would when we assume a threshold, as the number of 
days above the threshold is affected. Future research should explore the possible bias in 
using coarse global models for health impact assessments, considering the relationships 
between concentration and population in metropolitan regions, by comparing with 
regional models, and should increasingly use finer-resolution or nested CTMs. 
 Our results focus solely on O3-related mortality and do not account for possible 
effects on particulate matter mortality from the same changes in emissions. We examine 
only the short-term impacts of O3 on mortality, for which years of life saved are 
unknown. We assume that the CRFs found in the US are valid globally, but populations 
across the world have different health characteristics that may influence O3 impacts. The 
CRFs used here are corroborated by meta-analyses of short-term O3 epidemiology studies 
in Europe and the developing world, which show a similar association between O3 and 
mortality, but are somewhat inconsistent in the magnitude of the relationship. In addition, 
epidemiology studies could be subject to confounders, including correlated co-pollutants, 
that are as yet unknown.   
 Our results suggest that emission controls in one region affect O3 air quality and 
O3-related mortality in other world regions, with impacts outside the source region that 
are comparable to or even exceed the domestic (intra-regional) impacts. Confidence in 
these estimates would be increased by resolving uncertainties, including domestic O3 
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responses to emission reductions and O3 CRFs around the world. Despite uncertainties, 
our results point to widespread impacts of emission reductions, suggesting that collective 
international agreements over larger spatial scales may be needed to address local 
mortalities due to O3 pollution (Holloway et al. 2003; Keating et al. 2004). 
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3.5. Tables and figures 
Table 3.1. Population-weighted reduction in annual mean O3 concentration (ppb) in 
receptor regions following 20% NOx, NMVOC, and CO emission reductions in each 
source region, based on 2006 population (billions, italics) (Oak Ridge National 
Laboratory 2008). 
Source 
Region 
Receptor Region 
NA EA SA EU 
0.481 1.67 1.55 1.02 
NA 0.960 0.183 0.149 0.349 
EA 0.184 1.200 0.146 0.168 
SA 0.059 0.112 1.890 0.066 
EU 0.150 0.221 0.165 0.589 
 
 
 
 
  
 
 
5
9
 
 
 
Figure 3.1.  Annual avoided cardiopulmonary mortalities per 1000 km
2
 (left) and per million people (right) resulting from 20% NOx, 
NMVOC, and CO emission reductions in the region shown and a 20% global CH4 mixing ratio reduction, assuming no low-
concentration threshold. 
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Table 3.2. Annual avoided cardiopulmonary mortalities (hundreds) following 20% NOx, 
NMVOC, and CO emission reductions in each region, assuming no concentration 
threshold and assuming a concentration threshold of 35 ppb (italics). Confidence intervals 
(95%) reflect uncertainty in the CRF only (Bell et al. 2004). 
Source 
Region 
Receptor Region 
NA EA SA EU NH 
NA 
9 (4 - 13) 7 (3 - 10) 6 (3 - 9) 11 (5 - 17) 36 (18 - 55) 
9 (4 - 14) 4 (2 - 6) 5 (3 - 8) 6 (3 - 9) 27 (13 - 41) 
EA 
2 (1 - 3) 43 (21 - 66) 6 (3 - 9) 5 (3 - 8) 59 (29 - 91) 
1 (1 - 2) 40 (19 - 61) 5 (2 - 8) 3 (1 - 4) 49 (24 - 76) 
SA 
1 (0 - 1) 4 (2 - 6) 76 (37 - 117) 2 (1 - 3) 85 (41 - 130) 
0 (0 - 1) 3 (1 - 4) 66 (32 - 101) 1 (0 - 2) 71 (34 - 108) 
EU 
2 (1 - 3) 8 (4 - 12) 6 (3 - 10) 17 (8 - 26) 38 (18 - 58) 
1 (0 - 1) 6 (3 - 8) 6 (3 - 9) 25 (12 - 38) 40 (19 - 61) 
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Figure 3.2.  Annual avoided non-accidental mortalities (hundreds) in each region from 
20% NOx, NMVOC, and CO emission reductions in the same region using the CRF and 
confidence interval (95%) from Bell et al. (2004) (solid bars), using the CRF from Bell et 
al. (2004) and confidence intervals (68%) from ±1 standard deviation of the model 
ensemble ozone perturbation in each grid cell (Fiore et al. 2009) (white bars), and using 
the mean and confidence intervals (95%) of the CRFs from three meta-analyses of O3 
mortality (Bell et al. 2005; Ito et al. 2005; Levy et al. 2005) (striped bars). We convert the 
CRFs of Ito et al. (2005) and Levy et al. (2005) for 1-hr maximum O3 concentrations to 
24-hr mean using a ratio of 1-hr maximum to 24-hr mean equal to 2 (Levy et al. 2005).       
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Table 3.3.  Population-weighted reduction in annual mean surface O3 (ppb) and annual 
avoided cardiopulmonary and total non-accidental mortalities (hundreds) over each 
region and the entire NH following a 20% reduction in the global mean CH4 abundance, 
assuming no concentration threshold.  Confidence intervals (95%) reflect uncertainty in 
the CRF only (Bell et al. 2004). 
Receptor 
Region 
Population-
weighted ΔO3 
(ppb) 
Avoided 
Cardiopulmonary 
Mortalities 
(hundreds) 
Avoided 
Non-accidental 
Mortalities 
(hundreds) 
NA 1.11 11 (5 - 17) 19 (10 - 29) 
EA 1.08 38 (19 - 59) 58 (30 - 86) 
SA 1.19 48 (23 - 73) 83 (43 - 123) 
EU 1.23 39 (19 - 59) 58 (30 - 86) 
NH 1.12 160 (77 - 244) 271 (141 - 401) 
 
 
Table 3.4.  Population-weighted reduction in annual mean surface O3 (ppb) and annual 
avoided cardiopulmonary and total non-accidental mortalities (hundreds) in the NH 
following a 20% reduction in anthropogenic CH4 emissions in each region relative to the 
base simulation, assuming no concentration threshold. Confidence intervals (95%) reflect 
uncertainty in the CRF only (Bell et al. 2004). 
Source 
Region 
Population-
weighted ΔO3 
(ppb) 
Avoided 
Cardiopulmonary 
Mortalities 
(hundreds) 
Avoided 
Non-accidental 
Mortalities 
(hundreds) 
NA 0.145 21 (10 - 31) 35 (18 - 52) 
EA 0.166 24 (11 - 36) 40 (21 - 59) 
SA 0.150 21 (10 - 33) 36 (19 - 54) 
EU 0.140 20 (10 - 31) 34 (18 - 50) 
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Figure 3.3.  Seasonality of Health Import Sensitivity (the ratio of foreign vs. domestic 
impacts on cardiopulmonary mortalities) in NA, assuming no threshold. 
  
 
Chapter 4. Impacts of global, regional, and sectoral black carbon emission 
reductions on surface air quality and human mortality 
(Anenberg, S. C., Arunachalam, S., Talgo, K., Dolwick, P., Jang, C., West, J. J. In 
preparation for Atmospheric Chemistry and Physics)  
4.1. Introduction 
 Black carbon (BC) is a component of fine particulate matter (PM2.5) produced by 
incomplete combustion of fuel and is mainly emitted by residential, transportation, and 
industrial sources (Bond et al. 2004). PM2.5 is associated with negative health impacts, 
including premature mortality (e.g. Krewski et al. 2009), and some evidence suggests that 
PM2.5 mixtures containing high BC fractions may have larger mortality effects than other 
mixtures (e.g. Smith et al. 2010b). BC also warms the atmosphere by absorbing solar 
radiation (Horvath 1993), indirectly impacts cloud lifetime and reflectivity (e.g. Koch and 
Del Genio 2010), and deposits on snow and ice, reducing albedo and quickening melting 
(Hansen et al. 2004). Although the net effects of BC on climate remain uncertain, 
mitigation of BC emissions offers an opportunity to address climate change and air 
pollution simultaneously (e.g. Jacobson 2002; Bond and Sun 2005; Ramanathan and 
Carmichael 2008; Kopp and Mauzerall 2010).  Both climate and health benefits should 
therefore be considered when evaluating mitigation strategies. 
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 While several recent studies have examined the climate impacts of BC emissions 
(e.g. Koch et al. 2007; Reddy et al. 2007; Levy et al. 2008; Shindell et al. 2008; 
Fuglestvedt et al. 2009), the associated health impacts have been studied less extensively.  
In contrast with direct atmospheric warming by BC absorption of sunlight, which 
depends on total column BC concentrations, BC health impacts depend on population 
exposure at the surface, where humans breathe. In addition, the net climate impacts of BC 
emitting sources can be offset by co-emitted PM2.5 components that reflect radiation, such 
as organic carbon (OC) and sulfate (SO4) (Unger et al. 2010), but all PM2.5 components 
are thought to be damaging to health.  Since the drivers for climate and health impacts of 
BC emissions differ, mitigation strategies that achieve the greatest near-term climate 
benefits may not yield the greatest co-benefits for public health, and vice versa.   
 Previous studies of the health impacts of outdoor air pollution have found that the 
greatest burden of outdoor air pollution on human health occurs in Asia, where large 
populations are exposed to high ozone and PM2.5 concentrations (Cohen et al. 2004; 
Anenberg et al. 2010), and that biofuel combustion causes eight times more premature 
deaths globally than fossil fuel emissions, largely because biofuel combustion occurs 
mainly in very populated regions of the world (Jacobson 2010).  Surface BC 
concentrations, specifically, have also been found to be highest over East Asia, South 
Asia, and Southeast Asia (e.g. Koch et al. 2009). The co-location of high BC 
concentrations and large populations may translate into a substantial impact on global 
public health, and significant potential benefits of BC mitigation.   
 Quantifying the health benefits of BC emission reductions and their variation by 
source region and sector may inform strategies to mitigate near-term climate change and 
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air pollution simultaneously. Here, we calculate the surface air quality and premature 
human mortality impacts of halving anthropogenic BC emissions globally, regionally, 
and from three major economic sectors. We also examine a scenario in which BC and OC 
emissions are reduced together, as they are co-emitted and likely to both be affected by 
BC mitigation strategies. We simulate PM2.5 concentration changes with a global 
chemical transport model (CTM) and calculate mortality changes using a health impact 
function based on epidemiologically-derived concentration-response relationships.  
 
4.2. Methods 
4.2.1. Model setup 
 We simulate a base case and several sensitivity cases using the global CTM 
MOZART-4 (Model of Ozone And Related Tracers, version 4) (Emmons et al. 2010).  
MOZART-4 has 85 gas-phase species and 39 photolysis and 157 gas-phase reactions.  
The representation of tropospheric aerosols includes sulfate (SO4; assumed here to exist 
as ammonium sulfate), BC, OC, secondary organic aerosol (SOA), ammonium nitrate 
(NO3), and sea salt (Emmons et al., 2010).  An online photolysis scheme accounts for the 
impact of aerosols on photolysis rates, affecting production of photochemical oxidants 
(Tie et al. 2005; Emmons et al. 2010).  Here, MOZART-4 is configured with a horizontal 
resolution of 1.9˚x1.9˚, 28 vertical levels, and is driven with meteorology from the 
NCEP/NCAR reanalysis (6 hour timestep) (Kistler et al. 2001; Kalnay et al. 1996) for the 
year 2002 with six months of spinup starting in July 2001. BC and OC are initially 
emitted as 80% and 50% hydrophobic and are converted to hydrophilic with a time 
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constant of 1.6 days to simulate the gradual coating of hydrophobic particles with sulfate 
and other compounds (Emmons et al. 2010).  Dry deposition of BC and OC is set to 0.1 
cm s
-1
 and wet deposition of hydrophilic BC and OC is set to 20% of the wet deposition 
rate of HNO3 (Tie et al. 2005; Emmons et al. 2010).  
 Anthropogenic BC and OC emissions for the year 2000 are from the inventory 
developed for the Intergovernmental Panel on Climate Change Fifth Assessment Report 
(IPCC AR5), based on Bond et al. (2007) and Junker and Liousse (2008) with updates 
described by Lamarque et al. (2010). Since this inventory includes only submicron 
particles, we multiply BC and OC emissions by 1.15 and 1.4 to include all particles up to 
2.5 µm in diameter for these species (Cooke et al. 1999), as in Liu et al. (2009b). The 
IPCC AR5 inventory reports emissions from the residential, transportation, and industrial 
sectors (includes non-road transportation), and smaller sectors, such as waste treatment, 
agricultural waste burning, and shipping. The residential, industrial, and transportation 
sectors together comprise >90% of the total anthropogenic BC inventory (Figure 4.1). As 
BC and OC are generally co-emitted with CO (e.g. Dickerson et al. 2002), we vary these 
emissions monthly by scaling to the monthly profile of CO from the RETRO emissions 
inventory (http://retro.enes.org/data_emissions.shtml), which does not include BC and 
OC, in each grid cell and sector (Figure C.1 and Figure C.2).  
 Anthropogenic emissions of all other species are those used by Emmons et al. 
(2010b), which are from the POET (Precursors of Ozone and their Effects in the 
Troposphere) (Olivier et al. 2003; Granier et al. 2005) inventory for the year 2000, with 
Asian emissions replaced by the annually varying Regional Emissions Inventory in Asia 
(REAS) (Ohara et al. 2007) (Table C.1). Biomass burning emissions for all species are 
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from the Global Fire Emissions Database version 2 (GFED2) (Van der Werf et al. 2006) 
for the specific months in 2001 and 2002 modeled here. To account for emission altitude 
and plume buoyancy, we distribute all biomass burning emissions vertically up to 6 km 
above the surface using the vertical profile from Dentener et al. (2006). All other 
emissions are injected at the surface, including power generation (<1% of global BC 
emissions) and industrial emissions, which include non-road transportation and small 
sources with no smokestacks.  
 Relative to this base case, we calculate changes in PM2.5 concentration and 
mortality for 12 sensitivity cases wherein anthropogenic BC emissions are halved 
globally, individually in eight major world regions (North America, South America, 
Europe, the Former Soviet Union, Africa/Middle East, South Asia (India), East Asia 
(China), and Southeast Asia/Australia) plus in the United States (US) alone, and 
individually in three major economic sectors (residential, industrial, transportation). 
These regions are defined in Table 4.1 and Figure C.3. We also examine a scenario in 
which global anthropogenic BC+OC emissions are halved together, since they are co-
emitted.  Because each source emits BC and OC in different ratios and each control 
measure may reduce them in different percentages, this experiment is meant to be 
illustrative of including OC reductions and does not represent the impacts of actual 
mitigation measures. We use simulated concentrations in the first vertical level 
(height=~80m) as surface concentrations. We multiply simulated hydrophobic and 
hydrophilic OC concentrations by 1.3 and 1.7 to account for associated species other than 
carbon (Ming et al. 2005) and add this to SOA to give total organic mass (OM). We 
estimate PM2.5 as BC+OM+SO4+NO3, assuming that these species exist entirely as PM2.5 
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and ignoring other species (dust and sea salt) that are dominated by natural emissions and 
are unaffected by changing BC and OC emissions. 
 
4.2.2. Evaluation of base case surface concentrations 
 Simulated annual average PM2.5 concentrations are highest in EA and IN, due to 
large anthropogenic and biomass burning emissions (Table 4.1 and Figure C.4Figure 
C.8). BC is 3-5% of total PM2.5 among world regions and OM is 14-46% (Figure 4.2 and 
Table C.2). SO4 generally contributes the most to PM2.5, except for IN and EA, where 
OM and NO3 also contribute significantly, and SE/AU, where OM is high due to 
wildfires. Population-weighted average BC and NO3 concentrations are generally larger 
than simple average concentrations (Figure C.2), indicating closer co-location with 
population compared with OM and SO4, which are more widespread. 
 MOZART-4 has been evaluated extensively against satellite data and 
measurements at altitude and at the surface by Emmons et al. (2010) and Tie et al. 
(2005), who comprehensively evaluated the aerosol scheme specifically. Here we focus 
on changes in PM2.5 components at the surface, and therefore evaluate simulated BC, OC, 
and SO4 concentrations in the first vertical level.  Since modeled concentrations are 
volume averages over large grid cells, they are expected to represent concentrations in 
remote locations that are more homogenous better than in urban areas. We therefore 
compare simulated concentrations to surface observations in remote locations from the 
Interagency Monitoring of Protected Visual Environments (IMPROVE; 
http://vista.cira.colostate.edu/improve/) network for the US and the European Monitoring 
and Evaluation Programme (EMEP; http://www.emep.int/) network for Europe. Surface 
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observations outside of the US and Europe are limited. We compare modeled BC and OC 
with observations at 15 locations in China (Zhang et al. 2008) and eight in India (Beegum 
et al. 2009) from 2006. Each of these monitoring networks reports elemental carbon 
(EC), which is measured by optical rather than thermal-optical techniques and may be 
between 30% and 100% of BC; since the emissions inventory is more representative of 
EC than BC, comparing modeled concentrations with EC is most appropriate (Vignati et 
al. 2010). For OC, we compare observations with simulated concentrations prior to 
conversion to OM, and include SOA. We compare SO4 prior to mass conversion to 
ammonium sulfate. Although we simulate 2002 for our base case, for the model 
evaluation only, we ran the base case through 2003 to leverage additional observations 
from IMPROVE (available for both 2002 and 2003) and EMEP (available for July 2002-
June 2003). 
 Compared with observations from IMPROVE (average 2002-2003) for the US 
(Figure 4.3 andFigure C.9), BC is generally simulated within a factor of two (inside the 
dashed lines), with some simulated concentrations higher than observations in the 
Northwest, California, and Northeast, and lower than observations in the South. 
Simulated OC is generally lower than observations, particularly in the Southeast, likely 
due to unrealistically low simulated SOA concentrations, consistent with previous studies 
using MOZART-4 (Dunlea et al. 2009; Emmons et al. 2010). However, simulated OC is 
higher than observations in the Northwest.  Simulated SO4 generally matches 
observations in the East, but is higher than observations in the West (Figure C.10). 
Compared with observations from EMEP in Europe (average July 2002 to July 2003), 
simulated BC concentrations are generally lower than observations, particularly in the 
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West (Figures 4.3 and C.9). As for IMPROVE, simulated OC is lower than observations 
in Europe (Figures 4.3 and C.9) and simulated SO4 is higher than observations (Figure 
C.10). For the few observations available from China and India, simulated concentrations 
are within a factor of two of observations in remote locations, but are lower than 
observations in regional and urban locations (Figure C.11Figure C.12). Some of these 
discrepancies may be due to differences between volume averaged modeled 
concentrations in large grid cells and point measurements (Swall and Foley, 2009; 
Gilardoni et al. 2011), or the mismatch between 2006 measurements in Asia and 2002 
simulated concentrations. Measurement methods may also cause overestimation of 
ambient EC concentrations (Novakov et al. 2005), with the reflectance method for 
IMPROVE potentially measuring higher EC concentrations than the transmittance 
method used by EMEP (Pope et al. 2006). 
 Simulated simple (population-weighted) regional average surface NO3 
concentrations range as high as 10.6 (30.6) µg/m
3
 in EA and 6.3 (15.1) µg/m
3
 in IN 
(Figure 4.2 and Table C.2). While a lack of global NO3 measurements limits our ability to 
evaluate simulated concentrations, these concentrations are consistent with those 
simulated by other global CTMs (Park et al. 2004). Any biases in simulated NO3 
concentrations would not significantly affect our results, since NO3 varies little among 
the BC emission scenarios. 
 
4.2.3. Health impact function 
 We calculate avoided premature deaths in each grid cell using the change in 
simulated PM2.5 concentration between the base case and the emission reduction scenario 
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and a health impact function (HIF). Global CTMs have been used previously to estimate 
mortality due to total anthropogenic air pollution (Anenberg et al. 2010), long-range 
transport of air pollution (Duncan et al. 2008; Anenberg et al. 2009; Liu et al. 2009a; 
West et al. 2009b), future changes in emissions (West et al. 2006; West et al. 2007; Selin 
et al. 2009), changes in one sector’s emissions (Corbett et al. 2007; Barrett et al. 2010), 
fossil fuel and biofuel emissions (Jacobson 2010), and air pollution changes associated 
with carbon dioxide emissions (Jacobson 2008).  
 Here we use a log-linear relationship between long-term PM2.5 exposure and 
relative risk (RR), following Anenberg et al. (2010). RR>1 indicates that PM2.5 exposure 
increases risk of mortality. We use RR to calculate β, the concentration-response factor 
(CRF), and, as shown in Eq. (1), the attributable fraction (AF), the fraction of the disease 
burden attributable to the change in annual average PM2.5 (∆X). This HIF is applied in 
each grid cell by multiplying the AF by the baseline mortality rate (y0) and exposed 
population (Pop), as shown in Eq. (2). 
 
AF = (RR-1)/RR = 1 – exp-β∆X (1) 
∆Mort = y0 (1 – exp
-β∆X
) Pop (2) 
 
 Some evidence suggests that air pollution mixtures with high BC fractions, ―black 
smoke,‖ ―diesel PM2.5,‖ and ―traffic PM2.5,‖ have stronger associations with mortality 
than other mixtures (Cooke et al. 2007; Brunekreef 2009). Studies that use ambient BC 
concentrations as a marker for air pollution mixtures also find stronger associations with 
mortality than those using total PM2.5 (Ostro et al. 2007; Ostro et al. 2008; Bell et al. 
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2009; Peng et al. 2009; Smith et al. 2009). These studies are subject to substantial 
exposure error since BC is very spatially heterogeneous, potentially resulting in risk 
underestimation (Smith et al. 2009; Bell et al. 2010). However, evidence for differential 
toxicity of BC and BC-containing mixtures remains inconclusive.  We therefore assume 
that all mixtures of PM2.5 are equally potent in causing premature mortality and use the 
change in total PM2.5 in Eq. (2). 
 We calculate CRFs using estimates of RR of chronic mortality due to total PM2.5 
from Krewski et al. (2009), the latest reanalysis of the American Cancer Society PM2.5 
studies (e.g. Pope et al. 2002) and the largest among long-term PM2.5 mortality studies 
(e.g. Laden et al. 2006). For a 10 µg/m
3
 increase in PM2.5, RR was 1.06 (95% CI, 1.04-
1.08), 1.13 (95% CI, 1.10-1.16), and 1.14 (95% CI, 1.06-1.23) for total, cardiopulmonary, 
and lung cancer mortality in adults age 30+. These RRs were determined for the observed 
range of concentrations, 5.8-22.2 µg/m
3
, and the linearity of the concentration-response 
relationship was also demonstrated up to 30 µg/m
3
 based on 1979-1983 PM2.5 data. 
Causes of death differ globally from those in the US, and we estimate cardiopulmonary 
and lung cancer mortality, as they are more comparable around the world than all-cause 
mortality. We assume these CRFs apply globally, despite differences in health status, 
lifestyle, age structure, and medical care among global populations.  
 We use baseline cardiopulmonary and lung cancer mortality rates from the World 
Health Organization (2004; 2008b), population from the LandScan database (Oak Ridge 
National Laboratory 2008) from 2006 (Figure C.13), and the fraction of the population 
age 30+ (World Health Organization 2004) to be consistent with Krewski et al. (2009), as 
described by Anenberg et al. (2010) (see Table C.3).   
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4.3. Results 
4.3.1. Global emission reductions 
 Halving global anthropogenic BC emissions reduces the global annual average 
PM2.5 concentration by 33 ng/m
3
 (1.2%), ranging among regions from 43 ng/m
3
 in NA to 
453 ng/m
3
 in EA (Table 4.1 and Figure 4.4). Population-weighted average PM2.5 
concentrations decrease by 542 ng/m
3
 (1.8%) globally, ranging from 126 ng/m
3
 in 
AF/ME to 1201 ng/m
3
 in EA. Regional BC concentrations decrease 25-49%, with smaller 
percentage reductions in regions with frequent wildfires (e.g. SA, AF/ME, SE/AU; 
Figure 4.5a and Figure C.14). Wildfires are assumed to be natural and are therefore 
excluded from the emission reduction.  We estimate that these PM2.5 reductions would 
avoid ~157,000 (95% CI, 120,000-194,000) annual premature deaths worldwide (Table 
4.1 and Figure 4.6). In all regions except NA which has a relatively high baseline lung 
cancer mortality rate, >90% of avoided deaths are from cardiopulmonary disease. Over 
80% of global avoided deaths occur in EA, with 81,000 (95% CI, 61,000-100,000) 
avoided deaths, and IN, with 48,000 (95% CI, 37,000-59,000). These regions have large 
emissions and exposed populations, and IN also has high baseline cardiopulmonary 
mortality rates.  
 Estimated reductions in PM2.5 concentrations are generally smaller than reductions 
in BC concentrations due to increased SO4 production (Figure 4.5a).  Aerosols affect gas-
phase chemistry by absorbing or scattering radiation that drives photochemistry (He et al. 
1999; Liao et al. 1999; Castro et al. 2001).  Previous studies using regional models 
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(Jacobson 1998; Li et al. 2005) and global models (Martin et al. 2003), including using 
the aerosol scheme used in MOZART-4 specifically (Tie et al. 2005), find that high BC 
concentrations lead to reduced photolysis rates for O3 and nitrogen dioxide and, therefore, 
reduced O3 concentrations.  Here, we find that reduced BC concentration increases 
photolysis and leads to increased concentrations of O3, hydroxyl radical (OH), and 
hydrogen peroxide (H2O2), as shown in Figure C.15.  As described by Tie et al. (2001), 
gas-phase production of SO4 in MOZART-4 occurs via R1, while aqueous phase (in-
cloud) production occurs via R2 and R3, where S(IV) is total dissolved sulfur (HSO3 and 
SO3).  
 
 SO2 + OH  SO4 (R1)   
 S(IV) + O3  SO4 + products(R2)   
 S(IV) + H2O2  SO4 + products (R3)   
 
Through these reactions, increased concentrations of OH, O3, and H2O2 in response to BC 
emission reductions lead to enhanced SO4 production. The resulting SO4 increases are 
very small percentages of total PM2.5 (up to 0.7% in EA; Figure C.14) but since SO4 
concentrations are much larger than BC concentrations, they can offset up to 28% (in 
EA) of regional BC reductions (Figure 4.5a). We include changes to all PM2.5 species in 
our mortality calculation, but do not include O3 increases. 
 Halving global anthropogenic BC and OC emissions together reduces BC 
concentrations by the same amount as halving BC emissions alone, but OM is also 
reduced (Figure 4.5b), such that annual average PM2.5 reductions are larger by a factor of 
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four in NA to over eight in IN (Table 4.1).  These PM2.5 reductions are associated with ~8 
times more annual avoided deaths than is estimated for halving BC alone (Table 4.1).  
Here, changes in radiation absorption by BC and scattering by OM, which can increase 
the pathlength of solar radiation and accelerate photochemistry (e.g. Dickerson et al. 
1997), have opposing effects on gas-phase chemistry.  We find increases in OH and O3 
concentrations but decreases in H2O2 concentrations, resulting in mixed effects on SO4 
(Figure C.16).   
 Estimated avoided deaths from halving anthropogenic BC and BC+OC are 
consistent with estimates by Anenberg et al. (2010) of the global burden of anthropogenic 
PM2.5 on mortality (~3.7 million deaths) when multiplied by the fraction of PM2.5 that is 
BC (9%, 300,000 deaths) and OM (46%, 1.7 million deaths) in that study. The global 
burden estimate is twice our estimated deaths from halving BC, but only 1.6 times those 
from halving OC (1.16 million from halving BC+OC minus 0.2 million from halving BC 
alone). While both studies use the MOZART model, we use here an updated version, 
MOZART-4, which includes aerosol chemistry and interactions with radiation. Our 
methodology also differs for BC and OC emissions, assumptions for converting OC to 
OM, and years of emissions and meteorology. 
 
4.3.2. Regional BC emission reductions 
 We now examine the surface PM2.5 and mortality impacts of halving 
anthropogenic emissions in eight world regions individually. EA contributes 32% of 
global anthropogenic BC emissions, more than double the contribution from any other 
region (Figure 4.1). AF/ME and IN follow, with 13% and 12%.  
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 We find the greatest reductions in population-weighted PM2.5 occur within the EA 
(1262 ng/m
3
) and IN (733 ng/m
3
) source regions, due to high emissions (Table 4.2).  For 
all regions, the contribution of BC emissions from other regions to surface PM2.5 
concentrations is very small, although some transport occurs between FSU, AF/ME, and 
EU, which are close in proximity. For some regions, halving BC emissions leads to small 
increases in OH, O3, and H2O2 in distant regions, which enhance SO4 production where 
SO2 emissions are high, such as in EA (Figure C.17Figure C.18). Since BC 
concentrations are not greatly impacted outside of the source region, small SO4 increases 
in distant regions can lead to overall PM2.5 increases (Table 4.2). For example, halving 
BC emissions in IN increases population-weighted average PM2.5 by 20 ng/m
3
 in EA. The 
limited influence of extra-regional BC emissions on regional surface PM2.5 concentrations 
is consistent with other studies finding that BC comprises 0-3% of background surface 
aerosol concentrations (Liu et al. 2009b) and that foreign BC emissions contribute 0-5% 
of regional surface BC concentrations (TF HTAP 2010). 
 Halving BC emissions in EA avoids 85,000 (95% CI, 64,000-105,000) annual 
premature deaths globally, more than any other region, followed by IN with 47,000 (95% 
CI, 36,000-58,000). EA and IN contribute 53% and 31% to all avoided deaths from 
halving global BC emissions, 1.6 and 2.5 times greater than their contributions to global 
anthropogenic BC emissions, owing to large populations in both regions and high 
cardiopulmonary mortality rates in IN. The small SO4  increases in distant regions 
resulting from some regional BC emission reductions have very little impact on 
mortality.  To compare mortality impacts of BC emissions across regions, we calculate 
the mortality impacts per unit BC emissions reduced (Figure 4.7). Per unit emission, the 
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mortality impact of BC emissions is largest for IN (136 premature deaths avoided per Gg 
BC emitted), followed by EA (90). This is likely due to smaller per-unit impacts of 
within-region emission reductions on BC concentration for EA (Table 4.2) and higher 
baseline cardiopulmonary mortality rates in IN (Table C.3). 
 Halving NA emissions reduces PM2.5 in that region by 151 ng/m
3
 and avoids 
4,000 (95% CI, 3,000-5,000) annual premature deaths (12 per Gg BC reduced), 91% of 
which occur within the US. Compared with halving BC emissions in the US only, halving 
all NA emissions causes avoided deaths in NA to increase by 12% and in the US by 
1.6%, mostly in the Northeast and California near national borders (Figure C.19).  
 
4.3.3. Sectoral BC emission reductions 
 We next examine the impacts of halving global BC emissions from each major 
economic sector individually. Globally, 93% of anthropogenic BC emissions are 
estimated to be from three sectors: residential (38%), industrial (includes non-road 
transportation; 29%), and transportation (on-road only; 26%) (Figure 4.1). Each sector’s 
contribution to total anthropogenic BC emissions differs considerably by region, with 
transportation emissions estimated to contribute most in developed regions (55% in NA 
and 53% in EU), and the residential sector contributing most in developing regions (62% 
in IN and 56% in both AF/ME and FSU). In EA, 50% and 35% are from the industrial 
and residential sectors.  
 Globally, halving residential BC emissions impacts population-weighted average 
PM2.5 and mortality most, with 250 ng/m
3
 PM2.5 reduced and 74,000 (95% CI, 57,000-
91,000) annual avoided deaths (Table 4.3). Avoided deaths are likely underestimated for 
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the residential sector since we exclude changes in indoor exposure. The global mortality 
impacts of reducing industrial BC emissions are also large, while those from reducing 
transportation emissions are fewer. Halving residential, industrial, and transportation 
emissions contributes 46%, 35%, and 15% to the avoided deaths from halving all 
anthropogenic BC emissions. These contributions are 1.3, 1.2, and 0.6 times each sector’s 
portion of global BC emissions, owing to the degree of co-location with population 
globally. As for BC emissions, the relative magnitude of each sector’s impact differs 
substantially in developed versus developing regions. For example, in IN, residential, 
industrial, and transportation emissions contribute 66%, 18%, and 14% of the PM2.5 
decrease, while in NA these sectors contribute 15%, 19%, and 59%. Of the total avoided 
deaths from halving global anthropogenic BC emissions, 26% occur in EA from the 
industrial sector, and 20% occur in each of IN and EA from the residential sector. 
Impacts of residential BC emissions are underestimates since impacts due to indoor PM2.5 
exposure are excluded. 
 The mortality impact per unit BC emitted (―mitigation efficiency‖) in each region 
is similar regardless of the sector from which emissions were reduced (Figure 4.8) and 
follows the same pattern as for the regional reductions (Figure 4.7). The only exception is 
for the transportation sector in EA, for which reducing BC emissions has a smaller per 
unit impact on mortality relative to the residential and industrial sectors. While the 
industrial and residential sectors in EA have the greatest BC emissions (―mitigation 
potential‖), all three sectors in IN have the greatest overall mitigation efficiency. Outside 
of IN and EA, mitigation efficiency is greatest for FSU, SE/AU, and EU, while 
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mitigation potential is greatest for the residential sector in AF/ME and the transportation 
sector in EU and NA.  
 
4.4. Sensitivity analysis 
 For the results presented above, we assume that the CRFs estimated for the US 
apply globally, although simulated concentrations in some grid cells in Asia are higher 
than the range included in the ACS study (Table C.3). Current evidence does not support 
the existence of low or high thresholds beyond which changes in PM2.5 concentration 
have no impact on mortality (Krewski et al. 2009). However, while no long-term 
epidemiology studies have examined the relationship between PM2.5 concentration and 
mortality at higher concentrations, the marginal impact of PM2.5 on mortality may be 
smaller at higher concentrations (Pope et al. 2009; Smith and Peel 2010). Without 
quantitative evidence describing the concentration-response relationship at a wide range 
of concentrations, we examine the effect of low and high health effect thresholds on 
estimated deaths. 
 For the case where BC emissions are halved globally, applying a high-
concentration threshold of 50 µg/m
3
 (an assumption consistent with previous studies, e.g. 
Cohen et al. 2004) reduces global avoided deaths by 56%, 99.6% of which occurs in EA 
and IN (Figure 4.9) where concentrations most frequently exceed the threshold, but the 
majority (60%) of estimated avoided deaths still occur in these regions. Applying a low-
concentration threshold of 5.8 µg/m
3
, the lowest measured level in Krewski et al. (2009), 
reduces global avoided deaths by 2.1%, 33% and 22% of which occur in AF/ME and 
SE/AU.  
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 We also examine the effect of applying the significantly higher CRFs from the 
latest reanalaysis of the Harvard Six Cities cohort study (Laden et al. 2006) which found 
that for a 10 µg/m
3
 increase in PM2.5, RRs of cardiovascular and lung cancer mortality 
were 1.28 (95% CI, 1.13-1.44) and 1.27 (95% CI, 0.96-1.69). Consistent with the relative 
magnitudes of the RR estimates, using the RRs from Laden et al. (2006) increases 
estimated global avoided deaths by 45.1%, which is distributed around the world.  
 
4.5. Uncertainties 
 While we quantify uncertainty for mortality impacts from statistical error in the 
CRF, we are unable to quantify several other important uncertainties. Uncertainty in 
global BC emission inventories is estimated to be about a factor of 2, and could be 
comparatively larger for the residential and industrial sectors in developing regions, 
where emissions are more difficult to estimate (Bond et al. 2004; 2007).  Global 
anthropogenic BC emissions are also generally allocated to grid cells according to 
population, an assumption that may be more accurate for some regions and sectors than 
others.  Simulated BC concentrations vary widely among global CTMs due to differing 
assumptions for emissions and parameterization of aerosol processes, such as aging and 
wet deposition (Koch et al. 2009; Vignati et al. 2010).  These model variations may affect 
estimated mortality impacts more than uncertainty in the CRF, as has been shown for 
ozone (Anenberg et al. 2009). The coarse grid resolution of the global CTM also 
contributes to uncertainty, since it does not capture fine spatial gradients of 
concentrations, particularly around urban areas. As BC and a component of OM are 
directly emitted, this uncertainty may be particularly important for this study.  
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 Several uncertainties are also associated with health impact function parameters. 
We assume that all PM2.5 mixtures are equally toxic, despite substantial compositional 
variation around the world and some evidence suggesting that BC-containing mixtures 
may be more toxic than the average. Additional research is needed to identify differential 
toxicity of air pollutant mixtures (e.g. Smith et al. 2009; Dominici et al. 2010; Vedal and 
Kaufman 2011). We also assume that CRFs found in the US apply globally, despite 
differences in concentration levels, populations, lifestyle, age structure, and medical care. 
This assumption is supported by evidence suggesting that PM2.5-mortality associations 
are similar among different sub-populations in the US (Pope et al. 2009), though different 
sub-populations around the world likely have larger differences than those in the US, and 
by similar findings among short-term PM2.5 mortality studies around the world (Health 
Effects Institute 2010; Atkinson et al. 2011). We emphasize cause-specific mortality 
which may be more comparable around the world than all-cause mortality, but may result 
in underestimates of the total mortality impacts since other causes of death are likely also 
associated with PM2.5.  
 
4.6. Conclusions 
 We have estimated the impacts of global, regional, and sectoral BC emission 
reductions on surface air quality and human mortality using a global chemical transport 
model (CTM) to simulate PM2.5 concentrations and a health impact function to calculate 
mortality changes. We find that halving global anthropogenic BC emissions would 
reduce global population-weighted average PM2.5 by 542 ng/m
3
 (1.8%) and avoid 
157,000 (95% confidence interval, 120,000-194,000) annual premature deaths 
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worldwide, corresponding to 4% of PM2.5-related deaths (Anenberg et al. 2010) and 0.3% 
of all deaths.  Since the chemical and physical processes governing BC concentrations in 
MOZART-4 and our health impact function are approximately linear, these results can be 
scaled to estimate the surface air quality and health impacts of larger or smaller changes 
in BC emissions. We exclude the likely substantial morbidity benefits of reducing BC 
due to lack of data on baseline morbidity rates.  Morbidity impacts may not be directly 
proportional to mortality impacts because of differences in hospitalization rates and 
medical care around the world. 
 The vast majority of surface PM2.5 and health benefits from BC emission 
reductions occur within the source region. Some inter-regional transport occurs between 
FSU, AF/ME, and EU, which are close in proximity. Regional definitions used here are 
very broad, encompassing many countries, which obscures smaller-scale transport of 
pollution across political boundaries. While most of the avoided deaths from halving 
global anthropogenic BC can be achieved by halving EA emissions (54%), followed by 
IN emissions (31%), IN emissions have 50% greater mortality impacts per unit BC 
emitted than EA emissions.  
 Globally, the contribution of residential, industrial, and transportation BC 
emissions to PM2.5-related mortality is 1.3, 1.2, and 0.6 times each sector’s contribution 
to anthropogenic BC emissions, owing to the degree of co-location between that sector’s 
emissions and global population. Within each region, mortality per unit emission varies 
little by source sector; however, impacts of residential BC emissions are underestimates 
since impacts due to indoor PM2.5 exposure are excluded.  In addition, the coarse grid 
resolution used here does not capture the spatial scale at which actual exposure to 
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emissions from these sectors occurs (e.g. near roadways for the transportation sector). 
These results should be further studied at finer resolutions to better simulate actual 
exposure. 
 We find that reducing BC emissions increases regional SO4 concentrations up to 
28% of regional BC concentration reductions due to reduced absorption of radiation that 
drives photochemistry.  The SO4 increase lessens the health benefits of BC reductions, 
which are calculated based on total PM2.5 concentrations, but may enhance the climate 
benefit since SO4 scatters radiation.  We estimate ~8 times more avoided deaths when BC 
and OC emissions are halved together, suggesting that these results greatly underestimate 
the full air pollution-related mortality benefits of BC mitigation.   Several studies have 
examined the net climate impacts of the total emission mixture from individual economic 
sectors, finding that for some sectors, cooling agents such as SO4 and OM offset the 
warming impacts of BC (e.g. Koch et al. 2007; Unger et al. 2010). Since no pollutant is 
beneficial for health, future studies should assess the health impacts of individual 
economic sectors and mitigation measures, accounting for the full mixture of emissions 
and both outdoor and indoor exposure. Confidence in our results would also be 
strengthened by reducing uncertainties from emissions, model parameterization of 
aerosol processes, grid resolution, and PM2.5 concentration-mortality relationships over a 
range of concentrations, component mixtures, and populations.  
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4.7.  Tables and figures 
 
Figure 4.1. Anthropogenic BC emissions by region and sector after the IPCC emissions are scaled by 1.15 to account for particles 
larger than 1 µm in diameter. 
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Table 4.1. Simple and population-weighted annual average PM2.5 (ng/m
3
) concentrations for the base case and PM2.5 reduction, avoided 
cardiopulmonary and lung cancer deaths (in thousands), and percent of these deaths from cardiopulmonary disease due to halving global 
anthropogenic BC emissions and BC+OC emissions. Confidence intervals (95%, in parentheses) reflect uncertainty in the CRF only. 
 
Base Case PM2.5 
Concentration 
(µg/m3) 
 
Global 50% BC Reduction 
 
Global 50% BC+OC Reduction 
Receptor 
region 
Simple 
Average  
Population
-weighted 
Average 
 Simple 
Average 
ΔPM2.5 
(ng/m3) 
Population
-weighted 
ΔPM2.5 
(ng/m3) 
Avoided 
Deaths 
(x1000) % CP 
 Simple 
Average 
ΔPM2.5 
(ng/m3) 
Population
-weighted 
ΔPM2.5 
(ng/m3) 
Avoided 
Deaths 
(x1000) % CP 
 
   
    
 
    North 
America 
(NA) 
3.54 8.28  43 150 4 87.3  151 655 14 87.8 
   
  
(3 - 5) 
 
 
  
(11 - 18) 
    
    
 
    South 
America 
(SA) 
3.84 6.02  44 130 1 94.9  218 735 8 95.1 
   
  
(1 - 2) 
 
 
  
(6 - 9) 
    
    
 
    Europe 
(EU) 
9.77 13.4  147 230 8 91.1  772 1116 41 92.1 
   
  
(6 - 10) 
 
 
  
(31 - 51) 
    
    
 
    Former 
Soviet 
Union 
(FSU) 
5.87 12.29  60 177 5 96.1  466 1582 45 96.1 
   
  
(4 - 6) 
 
 
  
(34-55) 
 
   
    
 
    Africa/ 
Middle East 
5.32 7.21  64 126 5 97.4  454 941 36 97.5 
   
  
(4 - 6) 
 
 
  
(28-43) 
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(AF/ME)    
    
 
    
South Asia 
(India; IN) 
19.28 36.29  420 732 48 96.7  3533 6409 399 96.7 
   
  
(37-59) 
 
 
  
(312-
482) 
    
    
 
    East Asia 
(China; EA) 
27.98 70.17  453 1201 81 92.8  3483 9938 622 93.0 
   
  
(61-100) 
 
 
  
(480-
755) 
    
    
 
    Southeast 
Asia/ 
Australia 
(SE/AU) 
4.81 9.55  54 247 6 94.2  361 1713 40 94.3 
   
  
(4 - 7) 
 
 
  
(31 - 49) 
 
   
    
 
    World 2.75 29.7  33 542 157 94.1  221 4379 1205 94.4 
 
   
  
(120-
194)   
  
(932-
1463) 
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Figure 4.2. Simulated annual average concentration (µg/m
3
) of PM2.5 components for the 
base case (2002) by geographic region. 
  
89 
 
 
 
Figure 4.3. Comparison of simulated annual average surface BC and OC concentrations 
(µg/m
3
) with the IMPROVE surface monitoring network for remote locations in the 
United States (average of 2002 and 2003) for a) BC and b) OC (includes SOA), and with 
the EMEP surface monitoring network for Europe (average for July 2002 to June 2003) 
for c) BC and d) OC (includes SOA).  
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Figure 4.4. Reduction in annual average surface PM2.5 concentration (ng/m
3
) for the 
global, sectoral, and regional emission reductions relative to the base case. 
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Figure 4.5. Reduction in global and regional annual average concentrations (ng/m
3
) of 
PM2.5 species for halving global anthropogenic (a) BC emissions and (b) BC+OC 
emissions, relative to the base case. 
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Figure 4.6. Avoided annual cardiopulmonary and lung cancer deaths per 1000 km
2
, for 
the global, sectoral, and regional emission reductions relative to the base case. 
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Table 4.2. Reduction in population-weighted average PM2.5 concentration (first row for each receptor region, ng/m
3
) and annual 
avoided premature cardiopulmonary and lung cancer deaths (second row, thousands) in each receptor region after halving 
anthropogenic BC emissions in each source region. Confidence intervals (95%, in parentheses) reflect uncertainty in the CRF only.  
 
  
Source Region 
Receptor Region   NA SA EU FSU AF/ME IN EA SE/AU 
          NA 
 
151 -1 -1 -1 -1 -1 -2 -1 
 
4 (3 - 5) 0 0 0 0 0 0 0 
 
         SA 
 
0 129 0 0 0 0 0 0 
 
0 1 (1 - 2) 0 0 0 0 0 0 
          EU 
 
0 0 225 5 9 -1 -3 10 
 
0 0 8 (6 - 10) 0 0 0 0 0 
          FSU 
 
-1 0 39 135 23 -1 1 0 
 
0 0 1 (1 - 1) 4 (3 - 5) 0 0 0 0 
         AF/ME 
 
0 0 7 5 116 1 0 0 
 
0 0 0 0 4 (3 - 5) 0 0 0 
         IN 
 
-1 -1 -1 -1 0 733 4 0 
 
0 0 0 0 0 49 (37 - 59) 0 0 
         EA 
 
-4 0 -9 -3 -6 -20 1262 -9 
 
0 0 -1 (-1 - -1) 0 -1 (0 - -1) -2 (-1 - -2) 85 (64 - 105) -1 (-1 - -1) 
 
         SE/AU 
 
0 0 0 0 1 8 9 230 
 
0 0 0 0 0 0 0 5 (4 - 7) 
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Figure 4.7. Global annual avoided premature deaths (thousands; blue bars) and avoided premature cardiopulmonary and lung cancer 
deaths per Gg BC emissions reduced (red diamonds), for halving anthropogenic BC emissions in each source region relative to the 
base case. Confidence intervals (95%) reflect uncertainty in the CRF only. 
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Table 4.3. Population-weighted reduction in annual average PM2.5 (ng/m
3
) and annual avoided premature cardiopulmonary and lung 
cancer deaths (in thousands) for halving global BC emissions from each sector, relative to the base case. Confidence intervals (95%, in 
parentheses) reflect uncertainty in the CRF only. 
 
 Residential  Industrial  Transportation 
Receptor 
region 
 
Population-
weighted 
ΔPM2.5 
(ng/m3) 
Avoided 
deaths 
x1000 
 
Population-
weighted 
ΔPM2.5 
(ng/m3) 
Avoided 
deaths 
x1000 
 
Population-
weighted 
ΔPM2.5 
(ng/m3) 
Avoided 
deaths 
x1000 
 
 
  
 
  
 
  NA  22 1 (0 - 1)  29 1 (1 - 1)  88 2 (2 - 3) 
 
 
  
 
  
 
  SA  28 0 (0 - 0)  30 0 (0 - 0)  65 1 (0 - 1) 
 
 
  
 
  
 
  EU  50 2 (1 - 2)  42 1 (1 - 2)  124 4 (3 - 5) 
 
 
  
 
  
 
  FSU  99 3 (2 - 3)  32 1 (1 - 1)  33 1 (1 - 1) 
 
 
  
 
  
 
  AF/ME  65 2 (2 - 3)  21 1 (1 - 1)  31 1 (1 - 1) 
 
 
  
 
  
 
  IN  480 32 (25 - 39)  135 9 (7 - 11)  105 7 (5 - 9) 
 
 
  
 
  
 
  EA  461 32 (24 - 39)  602 41 (31 - 50)  89 5 (4 - 7) 
 
 
  
 
  
 
  SE/AU  115 3 (2 - 3)  50 1 (1 - 1)  71 2 (1 - 2) 
 
 
  
 
  
 
  World  250 74 (57 - 91)  191 55 (42 - 68)  80 23 (17 - 28) 
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Figure 4.8. Annual avoided premature cardiopulmonary and lung cancer deaths per unit 
BC emissions reduced vs. total BC emissions (Gg) for particular source sectors within 
each region. Avoided deaths are estimated in the three simulations where global 
emissions in each sector are halved, and shown for each receptor region; these deaths are 
compared with emissions from each region, assuming that deaths from inter-regional 
transport are negligible (Table 4.2).  Uncertainty in the mortality estimates is a factor of 
0.23 from the central estimate, which includes uncertainties in the cardiopulmonary and 
lung cancer CRFs only.  Uncertainty in BC emissions is assumed to be a factor of 2 from 
the central estimate (Bond et al. 2004; 2007).  Since these uncertainties are factor 
differences from the central estimate, they are identical for each data point. 
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Figure 4.9. Sensitivity of estimated avoided annual premature cardiopulmonary and lung 
cancer deaths from halving global anthropogenic BC emissions to a high concentration 
threshold (HCT) of 50 µg/m
3
, a low-concentration threshold (LCT) of 30 µg/m
3
, and 
relative risk estimates from Laden et al. (2006; cardiovascular and lung cancer mortality 
only).  Confidence intervals (95%) reflect uncertainty in the CRF only.  
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Chapter 5. Concluding remarks 
 Air pollution has historically been considered a local problem and has thus been 
regulated mainly on the national scale.  In some developed regions, health-based 
regulations such as the National Ambient Air Quality Standards (NAAQS) in the US 
have led to drastic declines in air pollution concentrations in the past few decades, even 
as economic development and industrial production expanded (US EPA 2008b).  These 
improvements are associated with substantial public health benefits that continue to 
accrue as downward emission trends persist (Hubbell et al. 2004; Fann and Risley, 2011).  
However, many areas within the US remain in nonattainment for O3 and PM2.5 (US EPA 
2008b), and evidence suggests that these pollutants affect health at levels below current 
standards (e.g. Jerrett et al. 2009; Krewski et al. 2009; Kim et al. 2011).  In addition, 
emissions are rising dramatically in some countries, particularly in developing regions, 
due to rapid population growth and economic development coupled with the absence of 
serious mitigation measures (Lamarque et al. 2010; TF HTAP 2010).  The proximity of 
these rising emissions with the greatest population centers of the world results in millions 
of people worldwide exposed to air pollution concentrations significantly higher than US 
and European standards (e.g. Health Effects Institute 2010). 
 This dissertation addresses several aspects of the global health impacts of air 
pollution, using global CTMs to simulate O3 and PM2.5 concentrations and 
epidemiologically-derived concentration-response relationships to calculate health 
impacts. Three case studies on the mortality impacts of all anthropogenic O3 and PM2.5 
  
99 
 
(Chapter 2; Anenberg et al. 2010), intercontinental O3 transport (Chapter 3; Anenberg et 
al. 2009), and BC emission reductions (Chapter 4; Anenberg et al. in prep.) demonstrate 
that air pollution remains a substantial problem for global public health with far-reaching 
impacts due to long-range transport and interactions with climate.  This chapter considers 
the key findings from Chapters 2-4 and their implications, as well as future research 
needed to address several critical knowledge gaps and uncertainties.   
 
5.1. Key findings and implications 
5.1.1. Global public health burden   
 Air pollution remains a serious public health problem globally.  O3 and PM2.5 
concentrations have been declining in developed regions as a result of regulation, but still 
likely cause widespread health effects, while air pollution is becoming worse in most 
developing nations.  In 2004, the World Health Organization (WHO) estimated that urban 
PM2.5 causes 800,000 annual premature deaths worldwide (Cohen et al. 2004).  This was 
considered an underestimate, as it was based on globally sparse surface concentration 
measurements in urban areas only and excluded ozone impacts.  Chapter 2 demonstrated 
that using a global CTM to simulate concentrations, including both PM2.5 and O3 in both 
urban and rural areas, yields an estimated 3.7 million annual premature deaths due to total 
anthropogenic PM2.5 and 700,000 due to O3, much larger than was previously estimated 
by Cohen et al (2004).  Results were about 50% larger using the same assumptions for 
concentration-response function and health effect thresholds, mainly due to two 
competing differences in methods.  While using a global CTM includes the total global 
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population, suggesting larger estimates, the coarse grid resolution may suppress high 
urban PM2.5 concentrations and, therefore, estimated PM2.5 mortalities.  The unique 
advantages of both observed and simulated concentrations should be leveraged in future 
studies to include the total population and exposure estimates at finer resolutions.  The 
Global Burden of Disease 2010 project (www.globalburden.org), expected to be 
completed in 2011, will address this goal by using global CTMs in conjunction with 
surface and satellite measurements to estimate the global burden of outdoor air pollution 
on mortality.  
 Each of the case studies examined here demonstrate that air pollution health 
impacts are driven not just by concentration, but also by population exposure and 
demographics.  For example, over 80% of the global air pollution-related deaths 
estimated in Chapter 2 occur in Asia, where population and concentrations are high, in 
addition to high baseline mortality rates in some areas.  Chapter 4 also found that 
compared with the transportation sector, BC emissions from the global residential and 
industrial sectors disproportionately impact health since they are predominantly located 
in highly populated areas of the world.  As modernization of medicine and healthcare in 
developing economies shifts major causes of death from infectious disease to chronic and 
degenerative diseases that are more affected by air pollution (e.g. cardiovascular disease, 
respiratory disease, and lung cancer) (Murray et al. 1997), the global burden of outdoor 
air pollution on mortality may rise in the future unless significant mitigation measures are 
enacted.  Some evidence also shows that temperature and air pollution may 
synergistically affect health (Ren et al. 2008; 2009), suggesting that future climate change 
may increase vulnerability to air pollution.  Additional research is needed to estimate how 
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the burden of outdoor air pollution on global mortality is expected to change in the future, 
taking shifting demographics and climate into account. 
 
5.1.2. Impacts on local and hemispheric scales 
 Aair pollution-related deaths result from exposure to both local air pollution and 
air pollution transported from foreign sources.  The atmospheric lifetime of PM2.5 (days 
to weeks) is shorter than that of O3 (weeks to months), and thus generally impacts 
concentrations and populations closer to the emission source.  Chapter 2 demonstrated 
that PM2.5 is the dominant contributor to the global burden of outdoor air pollution on 
premature mortality, suggesting that local emission controls are essential for mitigating 
air pollution-related mortality.  Chapter 4 also showed that per unit emission, reducing 
BC emissions from some world regions and economic sectors achieves greater health 
benefits than reducing emissions from others, due to atmospheric processes governing 
transport and lifetime, as well as co-location with susceptible populations.  Therefore, 
designing these local mitigation policies must consider local emission and exposure 
patterns which may differ by region. 
 However, Chapter 3 demonstrated that regional reductions of O3 precursor 
emissions affect health all around the world, even in areas far from the source region.  
Emission reductions in North America and Europe were estimated to avoid more 
premature deaths in other parts of the world than locally, due to large exposed 
populations in the receptor regions.   Of the avoided deaths from reducing emissions in 
North America, Europe, South Asia, and East Asia combined, foreign emission 
reductions contribute 30% in both North America, due to transported concentrations that 
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are large relative to concentrations from local emissions, and East Asia, due to large local 
populations exposed to smaller concentrations transported from other regions.  In Europe, 
foreign emission reductions contribute over 50% of resulting avoided deaths, largely due 
to the influence of North American emissions.  These results suggest that while local air 
pollution control is a critical component of efforts to prevent air pollution-related 
premature mortality, international cooperation in mitigation may be needed to address air 
pollution transported across political, and even continental, boundaries, as has been 
suggested elsewhere (Holloway et al. 2003; Keating et al. 2004; Global Atmospheric 
Pollution Forum 2010; TF HTAP 2010).  In addition, cost-benefit analyses for domestic 
air pollution policies such as those conducted routinely by the US EPA and European 
Commission are likely to underestimate the total health benefits by not accounting for 
benefits internationally (West et al. 2009b).   
 
5.1.3. Interactions with climate 
 Air pollution also interacts with climate, suggesting that limiting impact 
assessments to air pollution-related health impacts in a particular region excludes other 
important impact pathways occurring on both regional and global scales.  First, warming 
temperatures are expected to exacerbate air pollution through increased biogenic 
emissions, photochemical reaction rates, and more frequent air inversions (e.g. Bloomer 
et al. 2009; Jacob et al. 2009).  In addition, some pollutants traditionally regulated for 
their impacts on health, such as O3 and black carbon, affect climate by directly absorbing 
or reflecting solar and infrared radiation, indirectly impacting cloud lifetime and 
reflectivity, and reducing snow and ice albedo (e.g. Horvath 1993, Hansen and 
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Nazarenko 2004, Koch and Del Genio 2010).  Finally, greenhouse gases and air 
pollutions are often emitted by the same sources; therefore, actions aimed at mitigating 
either climate change or air pollution will likely also impact the other (e.g. West et al. 
2004; Reynolds and Kandlikar 2008; Bollen et al. 2010; Haines et al. 2010; Nemet et al. 
2010).  These case studies demonstrate that substantial benefits for global public health 
can be achieved by mitigating O3 (Chapter 3), methane (Chapter 3), and black carbon 
(Chapter 4), all of which are important climate warmers.   Controlling these short-lived 
climate warmers in the atmosphere may therefore achieve co-benefits for both health and 
climate (Hansen et al. 2000; Jacobson 2002; Bond and Sun 2005; West et al. 2006; 
Ramanathan and Carmichael 2008; Molina et al. 2009; Kopp and Mauzerall 2010).  
 Considering air pollution in a global context may allow identification of strategies 
that benefit both climate and air pollution simultaneously (―win-win‖) or those that 
achieve benefits for one without worsening the other (―win-no-lose‖).  Several integrated 
assessments that estimate the multiple benefits of air pollution mitigation on climate, 
health, agriculture, and ecosystems are currently underway.  These analyses focus on the 
integrated benefits of widespread international adoption of tighter on-road vehicle 
emissions standards, such as those currently in place in Europe (Shindell et al. in prep), 
and the benefits of mitigating short-lived climate forcers such as BC, O3, and methane 
(UNEP in prep).  Such integrated assessments should be increasingly used to inform 
policy decisions aimed at achieving both health and climate benefits.  
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5.1.4. Global health impact assessment methodology 
 Given the far-reaching impacts of air pollution on health, global health impact 
assessment is a useful tool to inform international policy decisions related to air pollution 
and climate change.  However, the methodology is complicated by data limitations and 
requires many assumptions and extrapolations of data from the US and Europe to the rest 
of the world.  Here, we improve upon the methodology used in the previous literature by 
refining the demographic information used as inputs into the health impact function.  
Specifically, country-specific baseline mortality rates are used in place of broad regional 
averages.  In addition, area-weighted average baseline mortality rates are used where 
gridcells overlapped multiple countries.  Finally, this work focuses on cause-specific 
mortality which is likely to be more comparable globally than all-cause mortality, since 
major causes of death vary dramatically around the world.  
 Despite these improvements, several critical knowledge gaps and uncertainties 
should be addressed to advance the quality of this methodology.  Figure 5.1 shows the 
cascade of uncertainties that permeates these case studies, as well as other global health 
impact assessments in the literature.  While these uncertainties should compound to 
produce a wide uncertainty range on the final health impact estimate, many of these 
uncertainties have not yet been studied extensively and are thus very difficult to quantify.  
The outcome is that these major uncertainties are discussed qualitatively and are left out 
of the quantitative uncertainty bounds around the mortality estimate.  Most global health 
impact assessments therefore include uncertainty only from the error in the relative risk 
estimate produced by the epidemiology studies, which gives a false illusion of precision. 
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 This work showed that the choice of the concentration-response function, in terms 
of magnitude, functional shape, and assumptions for the existence of health effect 
thresholds, substantially impacts mortality estimates.  For PM2.5, relative risk estimates 
from the latest American Cancer Society study (Krewski et al. 2009) were applied and 
linearly extrapolated to high concentrations in both Chapters 2 and 4.  However, in both 
cases, examining the effect of using the Harvard Six Cities Study relative risk estimates 
(Laden et al. 2006) and health effect thresholds showed that mortality estimates were 
sensitive to these choices, often changing by >50% of the estimated value under different 
assumptions.  Applying a log concentration-response function as has been suggested 
(Pope et al. 2009; Smith and Peel 2010) would also have a significant impact on 
estimated deaths, as evidenced by the substantial impact of high-concentration thresholds.  
For O3, we estimate short-term mortality in Chapter 3 but long-term mortality in Chapter 
2.  The body of evidence for short-term O3 mortality is much larger than that for long-
term mortality, but toxicology and controlled human exposure studies demonstrate 
biological plausibility for a long-term effect on respiratory mortality (National Academy 
of Sciences 2008).  Using long-term relative risk estimates for O3 yields mortality 
estimates that are about a factor of 2 higher than is estimated using short-term relative 
risk estimates (Anenberg et al. 2011).  Assumptions for concentration-response functions 
are thus critical choices in global health impact assessment. 
 In addition, while simulating exposure estimates with global CTMs allows full 
spatial coverage and examination of the impacts of hypothetical emission changes, 
surface concentrations simulated by CTMs remain uncertain. Neither global CTMs nor 
their inputs such as emissions were developed for the purpose of producing human 
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exposure estimates, and disagreements remain between simulated surface concentrations 
and observations, as well as among different CTMs (e.g. Fiore et al. 2009, Koch et al. 
2009). Major advancements in global CTMs have improved their quality in simulating 
concentrations that match observations.  However, current methods to evaluate simulated 
surface concentrations (as performed in Chapters 2 and 4) compare the simulated volume 
average of very large gridcells to measurements taken at specific points in space and time 
by surface monitors.  Such comparisons provide a reasonable ballpark evaluation, 
especially when measurements taken in remote locations are used, but future studies 
should increasingly supplement point measurements taken at the surface with data from 
other observational sources, such as satellite observations which can be used to infer 
surface concentrations (van Donkelaar et al. 2010).   
 Multi-model ensembles may remove potential biases introduced by individual 
models, increasing the confidence in simulated concentrations.  The multi-model 
ensemble analysis of long-range transport of O3 in Chapter 3 demonstrated that the 
models in the ensemble had a very large standard deviation for local impacts of O3 
precursor emission reductions.  The large standard deviation substantially influenced 
results, such that the relative magnitude of regional avoided deaths from local and foreign 
emission reductions changed when the mean + sd was used versus when the mean - sd 
was used.  In Chapter 2, Monte Carlo analysis was used to include uncertainty in 
simulated O3 and PM2.5 concentrations, but necessarily used crude assumptions for model 
uncertainty due to lack of established estimates.  A dedicated effort is necessary to 
examine the effect of uncertainty from simulated concentrations and other sources on 
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estimated deaths and to design methods to incorporate these various sources of 
uncertainties into the uncertainty bounds around the mortality estimate. 
 
5.2. Future research 
5.2.1. Incorporating future demographic shifts 
 This work found that the health impacts of air pollution are driven by both 
concentration and demographics of the exposed population.  Since air pollution 
mitigation policies can take years or even decades to implement and often remain in 
effect for decades, the health benefits of potential policies should be evaluated based on 
the demographics of the future population. To date, studies examining the impacts of 
future changes in air pollution on human health include population growth according to 
socioeconomic assumptions (West et al. 2006; West et al. 2007; Selin et al. 2009; 
Shindell et al. in prep; UNEP in prep), but none have incorporated shifts in baseline 
mortality rates.   
 Two methods of calculating future changes in cardiovascular, respiratory, and 
lung cancer mortality rates, the causes of death found to be most strongly associated with 
O3 and PM2.5 (Jerrett et al. 2009; Krewski et al. 2009), should be explored.  First, 
assuming economic development has a similar impact on mortality shifts in all regions of 
the world, income, as an indicator of economic development, can be used to relate 
epidemiological transitions that have already occurred in developed regions to those that 
are expected to occur in currently developing regions.  A second method is to leverage 
large-scale studies that monitor risk factors around the world, such as the World Health 
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Organization (WHO) Multinational Monitoring of Trends and Determinants in 
Cardiovascular Disease (MONICA) project, to predict future mortality changes.   
 Once future mortality rates are projected, they can be used in a case study on the 
health impacts of future changes in air pollution.  Projected changes in emissions that 
account for various degrees of economic development and pollution regulation have been 
developed for the Intergovernmental Panel on Climate Change (IPCC) Fifth Assessment 
Report (AR5) Representative Concentration Pathways (RCPs) and are readily available 
(http://www.iiasa.ac.at/Research/ENE/IAMC/rcp.html). These emission inventories can 
be leveraged to examine the future changes in surface air quality and human mortality for 
a variety of economic and policy scenarios.  Such an analysis would produce the first 
estimates of how the total burden of air pollution on mortality may change in the future, 
while simultaneously advancing the global health impact assessment methodology to 
incorporate future demographic shifts.   
 
5.2.2. Evaluating benefits of actual mitigation strategies 
 The changes in individual air pollutant emissions examined in Chapters 3 and 4 
are unrealistic since each emission source emits a mixture of pollutants.  Any mitigation 
strategy is likely to impact the entire emission mixture, rather than individual components 
alone.  Chapter 4 showed that halving co-emitted OC emissions along with BC emissions 
avoids eight times more premature deaths compared with halving BC alone, suggesting 
that mortality results greatly underestimate the full air pollution-related benefits of BC 
mitigation strategies, which generally decrease both OC and BC.  Each sector also 
produces emissions that result in different patterns of exposure, depending on where the 
  
109 
 
emissions occur (both horizontally and vertically) and the degree of co-location with 
population.   
 To identify emission sources that can be controlled to achieve the greatest 
benefits, the health impacts of individual economic sectors should be assessed, as has 
been done for climate (Koch et al. 2007; Reddy et al. 2007; Balkanski et al. 2010; Unger 
et al. 2010).  Only two studies have estimated the health burden of individual emission 
source sectors, focusing specifically on shipping and aircraft (Corbett et al. 2007; Barrett 
et al. 2010).  A natural first step would be to leverage the air quality modeling from 
Unger et al. (2010), in which each sector’s emissions were eliminated from the model 
individually, as inputs to the health impact assessment. This would allow for estimation 
of gridded sector-specific mortality impacts, which can then be aggregated by world 
region.  However, the horizontal resolution of the air quality model used by Unger et al. 
(2010) is 4°x5°, much coarser than the resolutions used in Chapters 2-4 and too coarse to 
reliably capture spatial gradients of population and concentrations.  Running a similar 
experiment on a finer resolution would be an improvement from these methods and can 
be performed relatively easily using emissions from the IPCC AR5 inventory, which are 
disaggregated by sector.  Finally, a more long-term and novel extension of this project 
would be to develop a tagging approach where each sector’s emissions and subsequent 
chemical products are included in the CTM simultaneously but are assigned as discrete 
variables. This method would account for any non-linearities in the photochemical 
system that would be affected by removing emissions from individual sectors.   
 Since the IPCC AR5 inventory projects emissions through 2100 following several 
assumptions of economic growth and air pollution regulation, building a framework to 
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assess the health impacts of individual economic sectors can be expanded to examine 
how the relative impacts of each sector can be expected to change in the future.  In the 
long run, this approach can be used to support international policy decisions by 
examining the benefits of actual international air pollution mitigation strategies. 
 
5.2.3. Understanding uncertainties and the value of information 
 The case studies examined here demonstrate that global health impact assessment 
is a useful tool to quantify the health impacts of air pollution and potential benefits of its 
mitigation, but major improvements are needed to enhance the quality and credibility of 
the methodology.  Figure 5.1 shows the cascade of uncertainties permeating these case 
studies and global health impact assessment in general.  Some sources of uncertainty are 
related to simulation of O3 and PM2.5 concentrations, including uncertainty in emissions 
inventories, the chemical and physical processes parameterized in global atmospheric 
models, and the horizontal and vertical resolution at which the atmospheric chemistry 
model is run.  While regional scale health impact assessments are increasingly 
approaching the fine spatial scales at which humans are exposed to air pollution in reality 
(Hubbell et al. 2009), due to computing power constraints, global CTMs are often run at a 
horizontal resolution of about 2°x2°, translating to grid cells approximately 170 km per 
side.  These grid cells are too coarse to capture the fine spatial gradients in concentration, 
and since the health impact assessment is performed on the same resolution as the 
simulated concentrations, population gradients are also diluted into the large grid area.  
Coarse grid resolution may cause oversimulation of O3 concentrations but 
undersimulation of PM2.5 concentrations (Anenberg et al. 2010).   
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 The importance of uncertainty from coarse grid resolution on estimated changes 
in mortality can be explored using global CTMs.  For example, one approach to explore 
is distributing concentrations of some species that have a very short atmospheric lifetime, 
such as carbonaceous aerosols, on a much finer grid within each grid cell according to 
population.  Another option would be to compare coarsely resolved simulated 
concentrations of both O3 and PM2.5 with observations from surface monitors or with 
concentrations simulated by a more highly resolved regional model to build sub-grid 
scale concentration gradients.  A third option would be to utilize fine-scale satellite 
observations in coordination with meteorological information to derive more finely 
resolved surface concentrations, as has been demonstrated by van Donkelaar et al. 
(2010).  The disadvantage of using satellite information is the inability to distinguish 
between PM2.5 components, though aerosol optical depth could potentially be used to 
differentiate absorbing and reflective components.  Finally, a fourth option would be a 
more complex task of running a global CTM with finer resolution grids nested within the 
coarse global grid, where the nested grids would be implemented over highly populated 
regions.  These approaches should all be considered for their potential value and effect on 
estimated deaths. 
 Other sources of uncertainty are associated with the concentration-response 
relationship, which is derived from epidemiology studies that relate O3 and PM2.5 
concentrations with mortality.  While short-term epidemiology studies performed around 
the world generally find consistent associations between acute O3 and PM2.5 exposure and 
daily mortality (Anderson et al. 2004; Health Effects Institute Scientific Oversight 
Committee 2004; Health Effects Institute 2010; Atkinson et al. 2011), the body of long-
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term epidemiology cohort studies, which are more resource-intensive, is limited to a few 
studies in the US and Europe.  To date, all global health impact assessments of PM2.5 
have extrapolated concentration-response relationships for chronic exposure found in the 
US and Europe to the rest of the world, despite differences in populations, lifestyles, age 
structure, medical care, and, perhaps most importantly, concentration levels.   
 While evidence from studies of exposure levels experienced by smokers and 
indoor air pollution concentrations, which tend to be much higher than ambient 
concentrations in the developing world, suggests that the marginal effect of a unit 
increase in PM2.5 concentration is smaller at higher concentrations (Pope et al. 2009; 
Smith and Peel 2010), the lack of epidemiology studies examining cohorts exposed to 
high ambient concentrations prevents conclusive determination of this relationship.  
Currently, there are several methods of extrapolating concentration-response 
relationships from low to high concentrations, with some studies assuming a linear 
extrapolation and others assuming a log function which flattens at high concentrations.  
While both assumptions may be justified given the lack of data at high concentrations, 
the assumed shape of the function has a substantial impact on estimated deaths, both in 
terms of the global total and the regional distribution.   
 Finally, PM2.5 composition is non-uniform and varies widely around the world 
depending on proximal emission sources and other factors.  Epidemiology studies 
examining differential toxicity of PM2.5 mixtures are limited, and despite short-term and 
toxicology studies suggesting otherwise (e.g. Ostro et al. 2007; Ostro et al. 2008; Bell et 
al. 2009; Peng et al. 2009; Wilker et al. 2010), all health impact assessments, global as 
well as domestic, assume all PM2.5 components and mixtures are equally toxic. Air 
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pollution epidemiology studies are increasingly moving from single pollutant studies to 
multi-pollutant studies (e.g. Dominici et al. 2010; Greenbaum et al. 2010) to support 
growing interest in multi-pollutant air quality management (e.g. Wesson et al. 2010), but 
there is no consensus yet on health impacts of different air pollution mixtures, or even 
how multi-pollutant epidemiology studies should be designed (Vedal and Kaufman, 
2011). Understanding of the differential toxicity of air pollution mixtures is therefore 
unlikely to be achieved in the near term.  In the meantime, research is needed to examine 
the assumption that all PM2.5 components and mixtures are equally toxic and the effect of 
that assumption on estimated deaths.   
 In summary, the uncertainties associated with global health impact assessment are 
not well studied and are very difficult to quantify. Prioritization of research needs can be 
achieved by analyzing the value of information for narrowing the uncertainty around each 
parameter.  Specifically, the above parameters that feed into the health impact function 
should be examined for the magnitude of their uncertainties, whether their uncertainties 
are symmetric around the mean, whether improvements to each source of uncertainty will 
likely narrow the uncertainty bands, whether narrowing the uncertainty bands will likely 
narrow the uncertainty on the mortality estimate, and whether narrowing the uncertainty 
on the mortality estimate will likely influence decisions on potential mitigation strategies.  
Evaluating these questions will help indicate the health impact function parameters and 
assumptions that should be prioritized for future research.  Results will to lead to 
additional research targeted at reducing uncertainty associated with the highest priority 
health impact function parameters.   
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5.3. Conclusion 
 This dissertation examined several aspects of the global health impacts of air 
pollution, finding that air pollution remains a substantial problem for global public health 
and is driven both by concentrations and by the demographics of the exposed 
populations.  In addition, while the impacts of black carbon largely occur within the 
source region, secondarily formed pollutants such as O3 and sulfate affect air quality and 
health on larger spatial scales.  These results suggest that international cooperation may 
be needed to complement local control efforts in mitigating local air pollution-related 
mortality and to mitigate air pollution and climate change in a coordinated way.  Finally, 
this work demonstrates that global health impact assessment is a useful tool to quantify 
the health impacts of air pollution and potential benefits of its mitigation, but 
improvements are needed to enhance the quality and credibility of the methodology.  
Future research should incorporate future demographic shifts, evaluate the impacts of 
realistic mitigation strategies, and assess the influence of various sources of uncertainty 
in global health impact assessment. 
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5.4. Tables and figures 
 
 
Figure 5.1.  Cascade of uncertainties in global health impact assessment.
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Appendix A. An estimate of the global burden of anthropogenic ozone and 
fine particulate matter on premature human mortality using atmospheric 
modeling: Supporting material 
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Figure A.1. Population-weighted annual average PM2.5 component concentrations from MOZART-2 simulations of the preindustrial 
(1860) and present (2000) (Horowitz 2006). NH4 is included in the values for NO3 and SO4, as all SO4 and NO3 are assumed to exist 
as (NH4)2SO4 and NH4NO3, following Ginoux et al. (2006).     
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Modeled Surface Ozone Comparison with Observations 
 We compare monthly mean surface ozone concentrations modeled with the Model 
of Ozone and Related Chemical Tracers, version 2 (MOZART-2) for the present day 
(2000) (Horowitz 2006) with observations from three non-urban networks, the Clean Air 
Status and Trends Network (CASTNet) for the US (Figure A.2), the European 
Monitoring and Evaluation Programme (EMEP) for Europe (Figure A.3), and the Acid 
Deposition Monitoring Network in East Asia (EANET) for Japan (Figure A.4). We also 
compare surface ozone with the Climate Monitoring and Diagnostics Laboratory 
(CMDL) monitoring network for remote locations around the world (Figure A.5). 
CASTNet and EMEP observations are from 2000, EANET observations are from 2001, 
and CMDL observations are from 1998-2004, depending on data availability. Overall 
mean bias is 2.9 ppb for CASTNet, -0.2 ppb for EMEP, 0.4 for EANET, and 2.5 ppb for 
CMDL. Since mean bias is within 3 ppb for all networks, we do not apply a bias 
correction for the main results, but examine the sensitivity to a concentration change of 
25% in both directions. Mortality results change about proportionally with concentration. 
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Figure A.2. Comparison of simulated monthly mean surface ozone concentrations (2000) 
with CASTNet monitored concentrations (2000) for the entire US and three subregions. 
 
  
120 
 
 
Figure A.3. Comparison of simulated monthly mean surface ozone concentrations (2000) 
with EMEP monitored concentrations (2000) for all of Europe and three subregions. 
 
 
Figure A.4. Comparison of simulated monthly mean surface ozone concentrations (2000) 
with EANET monitored concentrations (2001) for Japan. 
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Figure A.5. Comparison of simulated monthly mean surface ozone concentrations for 
2000, in ppb (Horowitz 2006), with CMDL monitored concentrations (1998-2004) for 
remote locations. 
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Health Impact Function Input Parameters 
Population 
 We use 2006 population from the Landscan database (Oak Ridge National 
Laboratory 2008), which apportions population to very fine resolution grid cells 
(30‖x30‖) based on nighttime lights, proximity to roads, and other indicators (Figure 
A.6). We also use the fraction of the population aged 30 and older for 14 world regions 
(World Health Organization 2004) to determine the exposed population consistent with 
Pope et al. (2002) for PM2.5 mortality estimates (Figure A.6 and Figure A.7). 
 
Figure A.6. Population aged 30 and older mapped on the MOZART-2 grid. 
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Figure A.7. Fraction of the population aged 30 and older (World Health Organization 
2004) mapped onto MOZART-2 grid. 
 
Baseline Mortality Rates 
 Baseline all-cause, non-accidental, cardiopulmonary, and lung cancer mortality 
rates for the population aged 30 and older for 66 countries and 14 world regions are from 
the World Health Organization (2004; 2008b) and are mapped onto the MOZART-2 grid 
(Figure A.8-Figure A.11). Where country-specific data are unavailable, we back-
calculate mortality rates from regional rates. When a grid cell contains portions of more 
than one country within it, we calculate an area-weighted average mortality rate using a 
Geographic Information System (GIS).  
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Figure A.8. Baseline all-cause mortality rates for the population aged 30 and older 
mapped on MOZART-2 grid. 
 
 
Figure A.9. Baseline non-accidental mortality rates for the population aged 30 and older 
mapped onto MOZART-2 grid. 
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Figure A.10. Baseline cardiopulmonary mortality rates for the population aged 30 and 
older mapped onto MOZART-2 grid. 
 
 
Figure A.11. Baseline lung cancer mortality rates for the population aged 30 and older 
mapped onto MOZART-2 grid. 
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Table A.1. Years of life lost per death, using 3% discount rate and age-weighting (World Health Organization 2008a) 
  
 Cardiopulmonary 
Disease 
Respiratory Disease Lung Cancer 
Africa 11.00 14.30 13.43 
North America 6.48 8.13 8.92 
Europe 7.40 5.93 10.04 
Asia 7.98 7.96 10.49 
South America 7.61 7.59 9.62 
Oceania 5.54 6.97 8.46 
World 7.89 8.93 9.77 
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Table A.2. As in Table 2.5. 
  
All-Cause (000s) 
Cardiopulmonary 
(000s) 
Lung Cancer (000s) 
Krewski et al. (2009)  3381 ± 986 3499 ± 864 222 ± 80 
 LCT=5.8 µg/m
3
 2378 ± 876 (-29.7%) 2506 ± 816 (-28.4%) 164 ± 68 (-26.1%) 
 LCT=7.5 µg/m
3
 2077 ± 822 (-38.6%) 2201 ± 780 (-37.1%) 146 ± 64 (-34.2%) 
 HCT=30 µg/m
3
 3059 ± 774 (-9.5%) 3205 ± 676 (-8.4%) 201 ± 68 (-9.5%) 
 HCT=50 µg/m
3
 3338 ± 940 (-1.3%) 3464 ± 826 (-1.0%) 219 ± 78 (-1.4%) 
Pope et al. (2002) avg.
a
  3378 ± 1516 (-0.0%) 2563 ± 1088 (-26.8%) 221 ± 86 (-0.5%) 
 LCT=5.8 µg/m
3
 2375 ± 1209 (-29.8%) 1835 ± 886 (-47.6%) 164 ± 73 (-26.1%) 
 LCT=7.5 µg/m
3
 2075 ± 1104 (-38.6%) 1612 ± 815 (-53.9%) 145 ± 68 (-34.7%) 
 HCT=30 µg/m
3
 3062 ± 1303 (-9.4%) 2332 ± 944 (-33.4%) 201 ± 75 (-9.5%) 
 HCT=50 µg/m
3
 3336 ± 1476 (-1.3%) 2534 ± 1062 (-27.6%) 219 ± 84 (-1.4%) 
Pope et al. (2002) 79-83
a
  2333 ± 1196 (-31.0%) 1800 ± 742 (-48.6%) 139 ± 72 (-37.4%) 
 LCT=5.8 µg/m
3
 1641 ± 935 (-51.5%) 1289 ± 609 (-63.2%) 103 ± 58 (-53.6%) 
 LCT=7.5 µg/m
3
 1433 ± 848 (-57.6%) 1132 ± 562 (-67.6%) 91 ± 54 (-59.0%) 
 HCT=30 µg/m
3
 2103 ± 1027 (-37.8%) 1624 ± 627 (-53.6%) 124 ± 62 (-44.1%) 
 HCT=50 µg/m
3
 2301 ± 1163 (-31.9%) 1777 ± 720 (-49.2%) 137 ± 71 (-38.3%) 
Laden et al. (2006)
b
  7714 ± 2736 (+128.2%) 4549 ± 1439 (+30.0%) 336 ± 198 (+51.4%) 
 LCT=5.8 µg/m
3
 5420 ± 2276 (+60.3%) 3208 ± 1236 (-8.3%) 249 ± 156 (+12.2%) 
 LCT=7.5 µg/m
3
 4732 ± 2102 (+40.0%) 2796 ± 1151 (-20.1%) 221 ± 142 (-0.5%) 
 HCT=30 µg/m
3
 7150 ± 2430 (+111.5%) 4308 ± 1331 (+23.1%) 316 ± 185 (+42.3%) 
 HCT=50 µg/m
3
 7651 ± 2685 (+126.3%) 4526 ± 1424 (+29.4%) 334 ± 196 (+50.5%) 
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a
 Pope et al. (2002) reported relative risk estimates for two time periods (1979-1983 and 1999-2000) and for the integrated average of 
both. The relative risk estimates for 1979-1983 were more conservative than those from 1999-2000 and the integrated average. 
b
 Laden et al. (2006) extended the follow-up of the Harvard Six Cities adult cohort study for eight years, finding significantly higher 
relative risk estimates for overall mortality than the original study and Krewski et al. (2009)
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Appendix B.   Intercontinental impacts of ozone pollution on human 
mortality:  Supporting material 
Methods 
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Table B.1. List of models and contact persons and the scenarios for which they 
were run 
Model Resolution 
(lon x lat x 
layers) 
Institution Model 
Contact 
SR2 SR6 
CAMCHEM-
3311m13 
2.5°x2°x30 NCAR, USA Peter Hess Y Y 
EMEP-rv26 (NH 
only) 
1°x1°x20 EMEP, Norway Jan Eiof 
Jonson 
Y Y 
FRSGC/UCI-v01 2.81°x2.81°x37 Lancaster 
University, UK 
Oliver Wild Y Y 
GEMAQ-v1p0 4°x4°x28 York 
University, 
Canada 
Alexandru 
Lupu 
Y Y 
GEOSChem-v07 2.5°x2°x30 Harvard 
University, 
USA 
Rokjin Park Y Y 
GEOSChemv07-
res4x5 
5°x4°x30 CIEMAT, 
Spain 
Marta Garcia 
Vivanco 
Y N 
GISS-PUCCINI-
modelE 
5°x4°x23 NASA GISS, 
USA 
Drew Shindell Y Y 
GMI-v02f 2.5°x2°x42 NASA GSFC, 
USA 
Bryan Duncan Y Y 
LMDz3-INCA1 3.75°x2.5°x19 LSCE, France Sophie Szopa Y Y 
LLNL-IMPACT-
T5a 
2.5°x2°x48 LLNL, USA Daniel 
Bergmann 
Y Y 
MOZARTGFDL-
v2 
1.88°x1.88°x28 GFDL, USA Arlene Fiore Y Y 
MOZECH-v16 2.81°x2.81°x31 FZ Julich, 
Germany 
Martin Schultz Y Y 
OsloCTM2 2.81°x2.81°x40 University of 
Oslo, Norway 
Michael Gauss Y N 
STOC-HadAM3-
v01 
5°x5°x19 University of 
Edinburgh, UK 
Ian 
MacKenzie 
Y Y 
STOCHEM-
HadGEM 
3.72°x2.5°x20 Met Office, 
Hadley Centre, 
UK 
Michael 
Sanderson 
Y N 
TM5-JRC-cy2-
ipcc-v1 
1°x1°x25 JRC, Italy Frank 
Dentener 
Elina Marmer 
Y Y 
UM-CAM-v01 3.72°x2.5°x19 University of 
Cambridge, UK 
Guang Zeng Y Y 
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Figure B.1. Map of source-receptor regions 
 
 
Figure B.2. Population (year 2006) per km
2
 mapped to 0.5 x 0.5 degree grid (Oak Ridge National Laboratory 2008) 
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Figure B.3. Baseline cardiopulmonary mortality rates mapped to 0.5 x 0.5 degree grid (World Health Organization 2004; 
2008b) 
 
Figure B.4. Baseline non-accidental mortality rates mapped to 0.5 x 0.5 degree grid (World Health Organization 2004; 2008b) 
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Results 
 
Table B.2. As Table 3.2, but for non-accidental mortalities. 
Source 
Region 
Receptor Region 
NA EA SA EU NH 
NA 
16 (8 - 23) 10 (5 - 15) 10 (5 - 15) 17 (9 - 25) 60 (31 - 89) 
16 (8 - 24) 6 (3 - 10) 10 (5 - 14) 9 (5 - 14) 45 (24 - 67) 
EA 
3 (2 - 5) 65 (30 - 96) 10 (5 - 15) 8 (4 - 12) 93 (48 - 137) 
2 (1 - 3) 60 (31 - 89) 9 (4 - 13) 4 (2 - 6) 77 (40 - 114) 
SA 
1 (1 - 2) 6 (3 - 9) 132 (70 - 196) 3 (2 - 4) 148 (77 - 218) 
1 (0 - 1) 4 (2 - 6) 115 (60 - 170) 2 (1 - 2) 123 (64 - 182) 
EU 
3 (1 - 4) 12 (6 - 18) 11 (6 - 17) 25 (13 - 37) 60 (31 - 89) 
2 (1 - 2) 8 (4 - 13) 10 (5 - 15) 37 (19 - 54) 62 (32 - 92) 
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Table B.3. Sensitivity of the annual avoided non-accidental mortalities (hundreds) from 20% NOx, NMVOC, and CO emission 
reductions in each region and the NH to changing parameters, assuming no concentration threshold.  For Case 1, confidence intervals 
(68%) are ±1 standard deviation of the model ensemble's ozone perturbation in each grid cell (Fiore et al. 2009) and do not reflect 
uncertainty in the CRF (Bell et al. 2004).  For Case 2, we use the mean and confidence intervals (95%) of the CRFs from three meta-
analyses of O3 mortality (Bell et al. 2005; Ito et al. 2005; Levy et al. 2005). Confidence limits for Case 2 reflect uncertainty in the 
CRF only. We convert the results reported by Ito et al. (2005) and Levy et al. (2005) for 1-hr. maximum O3 concentrations to 24-hr. 
mean O3 concentrations using a ratio of 1-hr. maximum to 24-hr. mean equal to 2 (Levy et al. 2005).  
 
Source 
Region 
Case 
Receptor Region 
NA EA SA EU NH 
NA 
1 16 (1 - 30) 10 (5 - 15) 10 (6 - 15) 17 (9 - 25) 60 (27 - 94) 
2 25 (17 - 32) 16 (11 - 21) 16 (11 - 21) 27 (18 - 35) 96 (66 - 124) 
EA 
1 3 (2 - 5) 65 (15 - 116) 10 (5 - 16) 8 (5 - 11) 93 (26 - 157) 
2 5 (4 - 7) 103 (71 - 134) 16 (11 - 21) 13 (9 - 17) 175 (101 - 192) 
SA 
1 1 (0 - 2) 6 (2 - 10) 132 (83 - 182) 3 (1 - 5) 148 (89 - 210) 
2 2 (1 - 2) 10 (7 - 13) 210 (144 - 273) 5 (3 - 6) 234 (161 - 304) 
EU 
1 3 (2 - 4) 12 (6 - 18) 11 (6 - 17) 25 (-9 - 58) 60 (9 - 111) 
2 4 (3 - 6) 19 (13 - 25) 18 (12 - 23) 39 (27 - 51) 96 (66 - 124) 
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Comparison of results with a previous health impact assessment using a regional-scale 
model 
 To understand the impact of the coarse grid resolution of the global model used 
here on our results, we compare our results for NA with a previous estimate of 415 
excess non-accidental mortalities in the US due to a population-weighted O3 increase of 
0.72 ppb, assuming a low-concentration threshold of 35 ppb (Jacobson 2008).  We 
estimate that O3 precursor emission reductions in NA reduce O3 by 0.96 ppb domestically 
(Table 3.1), resulting in about 1600 avoided premature mortalities in NA, assuming a 
threshold of 25 ppb (Table B.2). While we use similar baseline mortality rates and 
concentration-response factors, our results are expected to be higher due to the difference 
in population-weighted O3 change (0.96 ppb vs. 0.72 ppb) and the population of NA vs. 
the US [481 million (Table 3.1) vs. about 300 million]. In addition, Jacobson (2008) 
calculates mortalities only for the population exposed to four month average O3 
concentrations (July – November) above the 35 ppb threshold (184.8 million), while we 
include the population exposed each month to monthly average O3 concentrations above 
the 25 ppb threshold. Taking these differences into account, our results are similar to 
those calculated by Jacobson (2008), suggesting that the coarse resolution of the global 
model used here impacts results less than other assumptions, including thresholds and 
exposed populations. 
 
 
Method of inferring regional CH4 contributions to CH4 mixing ratio reduction 
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 Following the methods used by Fiore et al. (2009), we infer the contribution of 
20% anthropogenic CH4 emission reductions in each region to the O3 response, from the 
simulation where the global CH4 mixing ratio was decreased by 20% (SR2 vs. SR1). 
Accounting for the feedback of CH4 on its own lifetime and assuming that 60% of total 
global CH4 emissions are anthropogenic, a 20% reduction in the CH4 mixing ratio 
corresponds to an estimated 25.7% decrease in global anthropogenic CH4 emissions. 
Based on the percentage of global anthropogenic emissions occurring in each region, 
20% reductions of anthropogenic emissions in NA, EA, SA, and EU are estimated to 
produce 12.9%, 14.8%, 13.4%, and 12.5% of the O3 decrease from the SR1 to SR2 
scenario.  We scale the O3 decrease (SR2 minus SR1) by these percentages to calculate 
the annual avoided mortalities from 20% regional reductions in anthropogenic CH4 
emissions within the four regions. 
 
Table B.4. As   
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Table 3.3, but with a low-concentration threshold of 35 ppb. 
 
Receptor 
Region 
Avoided 
Cardiopulmonary 
Mortalities 
(hundreds) 
Avoided  
Non-accidental 
Mortalities 
(hundreds) 
NA 7 (3 – 10) 11 (6 – 17) 
EA 27 (13 – 41) 41 (21 – 60) 
SA 40 (19 – 61) 70 (37 – 104) 
EU 23 (11 – 35) 35 (18 – 51) 
NH 105 (51 – 161) 177 (92 – 262) 
 
 
 
Table B.5. As Table 3.4, but with a low-concentration threshold of 35 ppb. 
 
Source 
Region 
Avoided 
Cardiopulmonary 
Mortalities 
(hundreds) 
Avoided  
Non-accidental 
Mortalities 
(hundreds) 
NA 14 (7 - 21) 23 (12 - 35) 
EA 16 (8 - 24) 27 (14 - 40) 
SA 14 (7 - 22) 24 (13 - 36) 
EU 13 (7 - 21) 23 (12 - 34) 
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Figure B.5. Annual avoided cardiopulmonary mortalities from regional 20% 
anthropogenic CH4 emissions reductions for each source-receptor pair assuming no 
threshold, estimated as described in the text. Vertical black lines represent the 95% 
confidence interval in the CRF only (Bell et al. 2004).   
 
Seasonality of foreign and domestic impacts in NA 
 In NA, reducing O3 precursor emissions has the largest effect on domestic 
cardiopulmonary mortalities in the summer, when the impact of foreign emissions is 
smallest (Figure B.6). Domestic emission reductions increase wintertime mortality in 
NA, due to the wintertime increase in O3 following NOx emission reductions (Fiore et al. 
2009). Foreign precursor emission reductions impact mortality in NA the most during 
spring and least from July through September (Figure B.6), reflecting the seasonality of 
long-range transport (Fiore et al. 2009). Owing to data limitations, we do not include 
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seasonal changes in baseline mortality rates, nor possible seasonal changes in the CRF 
which are not well understood but may occur (National Academy of Sciences 2008). 
 
  
 
1
4
0
 
 
 
Figure B.6. Seasonality of avoided cardiopulmonary mortalities in NA due to (a) simultaneous 20% reductions in anthropogenic 
emissions of NOx, NMVOC, and CO within NA and (b) simultaneous 20% reductions in anthropogenic emissions of NOx, NMVOC, 
and CO within the three foreign regions (EA, SA, and EU) individually and summed together, assuming no threshold.     
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Appendix C.   Impacts of global, regional, and sectoral black carbon 
emission reductions on surface air quality and human mortality:  Supporting 
material 
 
 
 
Figure C.1. Monthly variation of global BC emissions by sector, according to seasonal 
variation of CO from RETRO inventory. 
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Figure C.2.  Monthly anthropogenic BC emissions by region, according to seasonal 
variation of CO from RETRO inventory. 
 
Table C.1.  Total global emissions of relevant species for base case year 2002, in 
Tg(species)/year.  NOx (NO+NO2) emissions are reported as NO. 
 
Species Emissions 
BC 8.6 
OC 41.2 
NOx 93.6 
SO2 149.5 
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Figure C.3.  Regional definitions, gridded to MOZART-4 grid. 
 
 
 
Figure C.4. Annual average concentration (µg/m
3
) of total PM2.5 for the 2002 base case 
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Figure C.5. As Figure C.4, but for BC 
 
 
Figure C.6. As Figure C.4, but for OM (includes SOA) 
 
  
145 
 
 
Figure C.7. As Figure C.4, but for SO4 
 
 
Figure C.8. As Figure C.4 but for NO3
  
 
 
1
4
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Table C.2. Simulated simple and population-weighted regional average base case concentrations of BC, OM, SO4, and NO3 (µg/m
3
). 
 
 
 BC  OM  SO4  NO3 
Region 
 
Simple 
Average 
Population-
weighted 
Average 
 
Simple 
Average 
Population-
weighted 
Average 
 
Simple 
Average 
Population-
weighted 
Average 
 
Simple 
Average 
Population-
weighted 
Average 
 
 
  
 
  
 
  
 
  
NA 
 
0.11 0.36 
 
0.76 1.54 
 
2.26 5.07 
 
0.41 1.32 
SA 
 
0.15 0.31 
 
1.36 1.75 
 
2.28 3.84 
 
0.05 0.13 
EU 
 
0.36 0.54 
 
1.41 1.86 
 
5.86 7.20 
 
2.14 3.79 
FSU 
 
0.17 0.45 
 
1.64 3.27 
 
3.31 6.11 
 
0.74 2.47 
AF/ME 
 
0.26 0.39 
 
2.09 2.99 
 
2.68 3.31 
 
0.30 0.53 
IN 
 
0.99 1.75 
 
6.33 11.32 
 
5.66 8.08 
 
6.31 15.14 
EA 
 
1.28 3.46 
 
5.61 14.35 
 
10.45 21.70 
 
10.65 30.64 
SE/AU 
 
0.23 0.66 
 
2.19 4.81 
 
1.62 3.06 
 
0.78 1.02 
World 
 
0.10 1.46 
 
0.68 7.42 
 
1.52 9.39 
 
0.45 11.43 
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Figure C.9. As Figure 4.3, but plotted on a spatial map to show a comparison of modeled 
and measured concentrations [(modeled-observed)/observed] in µg/m
3
. 
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Figure C.10. Comparison of simulated annual average surface SO4 concentrations with 
the IMPROVE surface monitoring network for remote locations in the United States and 
with the EMEP surface monitoring network for Europe (average 2002-2003). The panels 
on the right show a comparison of modeled and measured concentrations [(modeled-
observed)/observed] in µg/m
3
. 
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Figure C.11. Comparison of modeled annual average (2002) BC and OC with observed 
annual average EC and OC at 15 sites in China in 2006 (Zhang et al. 2008).  
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Figure C.12. Comparison of modeled annual average BC (2002) with observed EC in 
India for the pre-monsoon season (average January-May) at eight sites in India in 2006 
(Beegum et al. 2009).  
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Figure C.13. 2006 population from Landscan database (Oak Ridge National Laboratory 
2008) aggregated to MOZART-4 grid. 
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Table C.3. Population aged 30 and older, baseline total (for all population), 
cardiopulmonary (for the population ≥30), and lung cancer (for the population ≥30) 
mortality rates, and simulated simple and population-weighted average PM2.5 
concentrations (µg/m
3
) for the 2002 base case, for each region. 
 
  
Baseline Mortality Rates  
(% per year) 
  
Base Case 
PM2.5 
Concentration 
Range (µg/m3) Region 
Population 
30+ 
All-
cause 
Cardio-
pulmonary 
(30+) 
Lung 
Cancer 
(30+) 
      
NA 2.70E+08 0.723 0.488 0.072 0.32 - 17.82 
SA 1.50E+08 0.615 0.500 0.024 0.64 - 28.63 
EU 3.46E+08 1.000 0.735 0.061 1.08 - 29.87 
FSU 1.66E+08 1.514 1.421 0.055 0.57 - 27.49 
AF/ME 3.59E+08 1.206 0.746 0.014 0.40 - 23.71 
IN 5.87E+08 0.919 0.835 0.026 1.69 - 185.36 
EA 8.03E+08 0.741 0.679 0.046 2.26 - 233.65 
SE/AU 2.61E+08 0.599 0.490 0.040 0.11 - 86.89 
World 2.94E+09 0.858 0.676 0.038 0.10 - 233.65 
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Figure C.14. Percentage reduction in annual average concentrations (ng/m
3
) of PM2.5 
species for halving global anthropogenic BC emissions relative to the base case. 
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Figure C.15. Change in annual average surface SO4, OH, O3, and H2O2 concentrations 
(ppb) for halving global anthropogenic BC emissions relative to the base case. 
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Figure C.16. As Figure C.15 but for halving global anthropogenic BC+OC emissions.  
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Figure C.17. As Figure C.15 but for halving anthropogenic BC emissions in EA only. 
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Figure C.18. As Figure C.15 but for halving anthropogenic BC emissions in EU only. 
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Figure C.19. (a) Avoided premature deaths from halving US anthropogenic BC emissions 
relative to the base case, and (b) difference in avoided deaths from halving BC emissions 
in NA vs. the US only (NA reduction minus US reduction). 
 
  
 159 
 
Appendix D.   Guide to running MOZART-4 on UNC’s Kure cluster 
 
Running MOZART-4 requires three steps: compiling the pre-processor, compiling the 
model, and running the model. Compiling the pre-processor and model takes 10-15 
minutes and must only be done once for each model configuration. Running the model 
takes much longer and must be performed for each experimental setup. For example, if 
you change a chemical mechanism, you must re-compile the pre-processor and model. 
However, if you are only changing emissions inputs, you can run the model many times 
with different emissions after compiling the pre-processor and model only once. 
First create MOZART-4 directory hierarchy: 
/largefs/[onyen]/mz4.6/ 
 proc/ 
 model/ 
 run/ 
 
Compiling the pre-processor 
You should have six directories within the proc/ directory – bin/; bkend/; inputs/; output/; 
procfiles/; src/; tmp/ 
In the inputs/ directory, you should have a symbolic link to the mozpp executable in the 
proc/bin/ directory and a .inp input file. To compile the pre-processor, issue the following 
command in the inputs/ directory: 
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 ./mozpp mz4.test.inp 
If the pre-processor compiled successfully, you will have new files in the proc/output/ 
directory: 
 moz.mat.F90 
 moz.mods.F90 
 mozpp.subs.tar 
 moz.subs.F90 
 mz4.test.dat 
 mz4.test.doc 
 params.h 
Ignore each of these files except the .tar file, which you will need to compile the model, 
the .dat file, which you will need to run the model, and the .doc file which contains the 
specified run parameters. 
 
Compiling the model 
You should have several directories within the model/ directory: 
 Base 
 bin 
 chem 
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 OBJ 
 pp 
And several files: 
 Makefile 
 make_test 
Open the Makefile and redirect it to point to your netcdf library.  
Create a directory called ―pp_test/‖ and copy the .tar file you created in the proc step into 
this new directory.  Un-tar the .tar file you just copied over. 
 tar –xvf mozpp.subs.tar 
Edit make_test to point to the new pp_test/ directory (instead of pp/ (set 
ppdir=‖$pwd/pp_test‖). Check the name of the output executable listed in the make file.  
This will be the name of the file created in the bin/ directory. 
To compile the model, issue the following command: 
 ./make_test 
If the model compiles successfully, you will have a new executable in the model/bin/ 
directory with the name you specified in make_test.  Each time you create a new model 
configuration, create a new pp_XXXX/ directory, modify the make file to point to that 
pp_XXXX/ directory, and change the name of the output file to reflect the new 
configuration. 
 
Running the model 
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A new directory should be created for each model run. The name of the run directory 
should be logical and should refer to the unique parameters of that run.  
1) Create a directory named run_test/.  You will need several files in this directory: 
mz4.nml, run_mz4_openmp, runScript, sim.params.nml.  In addition, copy the .doc 
and .dat files from the proc/output/ directory into this directory.  Create hist/ and rest/ 
directories. 
The mz4.6/mozart_data/ directory includes all the input files needed for MOZART to 
run, including meteorological data, emissions, boundary conditions, initial conditions, 
etc.  
2) Change into the mozart_data directory.  Go into each directory and look at the header 
of several of the netcdf files by issuing the following command: 
 ncdump –h filename | less 
Piping the ncdump –h command through the less command displays the resulting 
information one page at a time. You can scroll through the pages using Page Up and Page 
Down. This header information tells you what variables are contained within the file, as 
well as some information on the source of the data and the years to which the data 
correspond. 
Some data, such as meteorology, changes daily. You may want to check to see the dates 
to which each file corresponds. To see the dates to which the meteorology files 
correspond, issue the following command: 
 ncdump –v date ncepfilename 
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Now the header information will be followed by a listing of the dates contained within 
the netcdf file. The dates correspond to the format YYYYMMDD. 
3) Edit the namelist file (mz4.nml) to specify how long to run, how often to write output 
and restart files, and file locations for meteorology, emissions, initial conditions, 
boundary conditions, etc. The namelist file should be edited for each model run. 
Typical output frequencies are monthly, daily, and hourly output files and monthly restart 
files. If for some reason, your model crashes while running, restart files allow you to 
restart the model at some mid-point, saving time and computing resources. To run the 
model in restart mode, copy the mz4.nml file to mz4.nml_restart. Change the ―sim_type‖ 
from ―INITIAL‖ to ―RESTART.‖ Make sure you also change your run_mz4 file to point 
to this new .nml file (or you can create a new run_mz4_restart file that points to the new 
.nml file – just make sure to submit run_mz4_restart to the queue instead of run_mz4).  
4) Edit the run scripts to point to the namelist file and the executable created in the 
model step: 
 run_mz4_openmp 
 runScript 
5) Run the model by invoking the following command: 
 bsub  < run_mz4_openmp 
The job has now been submitted to the default ―week‖ queue on Kure.  
6) Check to see that the job is running by issuing the following command: 
 bjobs 
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Your job should be listed with a status denoting PEND or RUN. When the job finishes, it 
will write out a log file, mz4.test.log.   If your run was successful, you will see a series of 
files in the hist/ directory named h0001.nc, ha0001.nc, hb0001.nc, hc0001.nc, hd0001.nc 
 
Useful rules to remember 
- The computing resources requested to run MOZART-4 are dependent on your choice 
of model resolution.  
o The number of CPUs requested must evenly divide into the number of latitudes. 
o There must be four latitudes at a minimum per MPI process 
For example, with 96 latitudes, the maximum number of CPUs that can be 
requested is 24. 
- The temporal resolution of restart files should match the temporal resolution of the 
history output files with the longest averaging time. For instance, if you are writing 
out history output files with monthly, daily, and hourly output files, you should write 
out monthly (or multiples of monthly) restart files. Restarting from the middle of the 
month may cause averaging errors in the monthly history output file. 
- All output variables must be specified in the ―input‖ file, except for aerosol optical 
depth variables, which must be specified in the .nml file. 
- UNC specific: 
o Running on Emerald requires a workaround to read the .nml file; Running on 
Kure does not. 
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o Running in hybrid MPI+OpenMP requires two run scripts on Kure, but only one 
on Emerald (examples below). 
o At least on Emerald, output files specified in the ―input‖ file must be separated 
into several smaller files. Otherwise, not enough memory. 
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Sample runscript on Emerald 
run_mz4: 
 
#!/bin/csh –f 
rm –f mz4.log 
#BSUB –n 16 
#BSUB –o mz4.log 
#BSUB –J mz4_run 
setenv LSF_PAM_HOSTLIST_USE unique 
setenv OMP_NUM_THREADS 4 
setenv KMP_STACKSIZE 96m 
setenv NL  mz4.nml 
setenv EXEC ../model/bin/mz4.6_mpi 
time mpirun.lsf –pam ―-n 4‖ $EXEC $NL 
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Sample runscripts on Kure 
run_mz4_openmp: 
 
#!/bin/csh –f 
rm –f mz4.test.log 
#BSUB –n 32 
#BSUB –o mz4.test.log 
#BSUB –J mz4_test 
#BSUB –q week 
setenv LSF_PAM_HOSTLIST_USE unique 
mpirun.lsf –pam ―-n 8‖ ./runScript 
 
runScript: 
 
#!/bin/csh –f 
setenv OMP_NUM_THREADS 4 
setenv KMP_STACKSIZE 96m 
setenv NL mz4.nml 
setenv EXEC ../model/bin/mz4.6_test 
$EXEC $NL 
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MOZART resources 
MOZART-4 wiki, maintained by Louisa Emmons at NCAR: 
https://wiki.ucar.edu/display/mozart4/Home 
NCAR MOZART-4 page: http://www.acd.ucar.edu/gctm/mozart/ 
Emmons et al. 2010 - Paper describing MOZART-4 published in Geoscientific Model 
Development: http://www.geosci-model-dev.net/3/43/2010/gmd-3-43-2010.html 
Larry Horowitz’s (GFDL) MOZART webpage for info on earlier versions: 
http://www.gfdl.noaa.gov/mozart 
MOZART on Wikipedia: http://en.wikipedia.org/wiki/MOZART_%28model%29 
Tie et al. 2005 – Paper describing aerosol scheme used in MOZART-4 published in G. 
Geophys. Res.: http://www.agu.org/pubs/crossref/2005/2004JD005359.shtml 
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